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ENHANCEMENT OF NMR AND MRI IN THE 
PRESENCE OF HYPERPOLARIZED NOBLE 
GASES 
This application claims the benefit of U.S. Provisional 
Application No. 60/014,321, filed March 29, 1996, the 
disclosure of which is incorporated by reference. 
FIELD OF THE INVENTION 
The present invention relates generally to nuclear mag 
netic resonance (NMR) techniques for both spectroscopy 
and imaging. More particularly, the present invention relates 
to the use of hyperpolarized noble gases (e.g., Xe and He) 
to enhance and improve NMR and MRI. 
BACKGROUND OF THE INVENTION 
Nuclear magnetic resonance (NMR) is an established 
technique for both spectroscopy and imaging. NMR spec 
troscopy is one of the most powerful methods available for 
determining primary Structure, conformation and local 
dynamic properties of molecules in liquid, Solid and even 
gas phases. As a whole-body imaging technique, Magnetic 
Resonance Imaging (MRI) affords images possessing Such 
Superb soft tissue resolution that MRI is the modality of 
choice in many clinical Settings. MRI can produce images 
which allow the clinician to distinguish between a patho 
logical condition and healthy tissue. For example, MR 
images clearly differentiate tumors from the Surrounding 
tissue. Further, using MRI it is possible to image specific 
regions within the organism and to obtain anatomical 
(morphology and pathology) and/or functional information 
about various processes including blood flow and tissue 
perfusion. Functional imaging of the brain is now also well 
documented. 
The structural and functional information available 
through MRI is complemented by whole-body NMR spec 
troScopy. NMR spectroscopic Studies on organisms provides 
a means to probe the chemical processes occurring in the 
tissue under Study. For example, the location and quantity of 
intrinsic NMR spectroscopic markerS Such as lactate and 
citrate can be Studied to gain insight into the chemical 
processes underlying a disease state (Kurhanewicz, J., et al., 
Urology 45: 459–466 (1995)). NMR spectroscopy can also 
be used to observe the effects of administered drugs on the 
biochemistry of the organism or the changes in the drug 
which occur following its administration (Maxwell, R. J., 
Cancer Surv. 17: 415-423 (1993)). Efforts to improve the 
information yield from MRI and NMR spectroscopy through 
increased Sensitivity or the use of appropriately designed 
extrinsic probes have been ongoing Since the inception of 
these techniques. 
Sensitivity poses a persistent challenge to the use of 
NMR, both in imaging and spectroscopy. In proton MRI, 
contrast is primarily governed by the quantity of protons in 
a tissue and the intrinsic relaxation times of those protons 
(i.e., T and T). Adjacent tissues which are histologically 
distinct yet magnetically Similar appear isointense on an MR 
image. AS the proton content of a tissue is not a readily 
manipulable parameter, the approach taken to provide dis 
tinction between magnetically Similar tissues is the intro 
duction into the biological System of a paramagnetic phar 
maceutical (i.e., contrast enhancing agent) Such as 
Gd(DTPA) (Niendorf, H. P., et al., Eur. J. Radiol., 13: 15 
(1991)). Interaction between the proton nuclei and the 
unpaired spins on the Gd" ion dramatically decrease the 
proton relaxation times causing an increase in tissue inten 
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sity at the site of interaction. Gd(DTPA) and analogous 
agents are Small molecular agents which remain largely 
confined to the eXuccellular compartment and do not readily 
croSS the intact blood-brain barrier. Thus, these agents are of 
little use in functional brain imaging 
Similar to MRI, NMR spectroscopic studies generally 
rely on detecting NMR active nuclei which are present in 
their natural abundance (e.g., H., P. "C) (Sapega, A. A., 
et al., Med. Sci. Sports Exerc., 25: 656-666 (1993)). 
Additionally, the chemical Species under observation must 
be spectroscopically distinguishable from the other com 
pounds within the window of observation. Thus, sensitivity 
in NMR spectroscopy is a function of both the abundance 
and the spectral characteristics of the molecule(s) desired to 
be studied. The range of NMR spectroscopic studies has 
been Somewhat expanded by the application of exogenous 
probes which contain NMR active nuclei, for example 'F 
(Aiken, N. R., et al., Biochim. Biophys. Acta, 1270: 52-57 
(1995)). 
Noble gases are of interest as tracers and probes for MRI 
and NMR spectroscopy (Middleton, H, et al., Magn. Res. 
Med. 33: 271 (1995)), however, the sensitivity of MRI and 
NMR spectroscopy for these molecules is relatively low. A 
factor which contributes to the lack of sensitivity of these 
techniques for the noble gases is that the Spin polarization, 
or net magnetic moment, of the noble gas Sample is low. For 
example, a typical molecule at thermal equilibrium at room 
tempe has an excess of Spins in one direction along an 
imposed magnetic field relative to those in the opposite 
direction of generally less than 1 in 10. Lower temperatures 
and higher fields, to the extent that these can be imposed, 
provide only limited benefit. Alternative approaches rely on 
disrupting the equilibrium magnetization by forcing mol 
ecules in the Sample into a polarZed State. Two methods 
known in the art for enhancing the Spin polarization of a 
population of nuclei are dynamic nuclear polarization and 
optical pumping. 
Dynamic nuclear polarization, originally applied to 
metals, arises from the croSS relaxation between coupled 
Spins. The phenomenon is known as the Overhauser Effect, 
with early disclosures by Overhauser and others (Ovehauser, 
A. W., “Polarization of nuclei in metals.” Phys. Rev. 92(2): 
411-415 (1953), Solomon, I., “Relaxation processes in a 
system of two Spins.” Phys. Rev. 99(2): 559–565 (1955), and 
Carver, T. R., et al., “Experimental verification of the 
Overhauser nuclear polarization effect,” Phys. Rev. 102(4): 
975–980 (1956)). The Nuclear Overhauser Effect between 
nuclear spins is widely used to determine interatomic dis 
tances in NMR studies of molecules in Solution. 
Optical pumping is a method for enhancing the Spin 
polarization of gases which consists of irradiating an alkali 
metal, in the presence of a noble gas, with circularly 
polarized light. The hyperpolarized gases that result have 
been used for NMR studies of surfaces and imaging void 
Spaces and Surfaces. Examples are the enhanced Surface 
NMR of hyperpolarized 'Xe, as described by Raftery, D., 
et al., Phys. Rev. Lett. 66:584 (1991); signal enhancement of 
proton and 'C NMR by thermal mixing from hyperpolar 
ized 'Xe, as described by Driehuys, B., et al., Phys. Let. 
A184: 88-92 (1993), and Bowers, C. R., et al., Chem. Phys. 
Lett. 205: 168 (1993), and by Hartmann-Hahn cross 
polarization, as described by Long, H. W., et al., J. Am. 
Chem. Soc. 115: 8491 (1993); and enhanced MRI of void 
Spaces in organisms (such as the lung) and other materials, 
as described by Albert, M. S., et al., Nature 370: 199-201 
(1994), and Song, Y.-Q., et al., J. Magn. Reson. A115: 
127-130 (1995). 
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Although hyperpolarized noble gases have proven useful 
as probes in the Study of the air spaces in lungs, the 
effectiveness or sensitivity of these methods is somewhat 
compromised for biological materials and organs, Such as 
blood and the parts of the body that are accessible only 
through the blood. During its residence time in the blood, the 
hyperpolarized gas is diluted considerably and the delay in 
transferring the gas from the lung Space to the blood 
consumes much of the time (e.g., T.) required for the 
polarized gas to return to its non-hyperpolarized State. 
Further complicating the Situation, the penetration of the 
hyperpolarized gas into the interior of red blood cells 
dramatically reduces the T of the hyperpolarized gas and 
thus, Sorely attenuates the temporal range over which the gas 
can Serve as an effective probe. 
A considerable advance in both MRI and NMR spectros 
copy could be achieved by the introduction of a versatile 
hyperpolarized noble gas-based NMR active tracer which 
could also function as a contrast enhancing agent or other 
wise affect, in a spectroscopically discernable manner, 
Sample molecules to which the probe is proximate. Among 
other applications, Such an agent would be useful in con 
junction with functional imaging of the brain and also to 
probe the dynamics of exchange between the intracellular 
and extracellular compartments of various tissues. Of even 
more profound Significance would be a means of delivering 
the tracer, either through the blood or via direct injection into 
the tissue of interest, which maintains the hyperpolarization 
of the gas during the delivery process and through the 
imaging or Spectroscopic experiment. Quite Surprisingly, the 
instant invention provides both Such a tracer and delivery 
method. 
SUMMARY OF THE INVENTION 
The present invention provides methods for using hyper 
polarized noble gases in conjunction with NMR spectroS 
copy and MRI. The noble gases are useful both as tracers, 
which are themselves detected, and also as agents which 
affect the magnetic properties of other nuclei present in a 
Sample. 
Thus, in a first aspect, the present invention provides a 
method for analyzing a Sample containing an NMR active 
nucleus, the method comprising: 
(a) contacting the sample with a hyperpolarized noble gas, 
(b) scanning the sample by nuclear magnetic resonance 
Spectroscopy, magnetic resonance imaging, or both 
nuclear magnetic resonance Spectroscopy and magnetic 
resonance imaging, 
(c) detecting the NMR active nucleus, wherein the NMR 
active nucleus is a nucleus other than a noble gas. 
In another aspect, the present invention provides a method 
for analyzing a sample which comprises: (a) combining a 
hyperpolarized noble gas with a fluid to form a mixture; (b) 
contacting the sample with the mixture; and (c) Scanning the 
Sample, the noble gas or both the Sample and the noble gas 
by nuclear magnetic resonance Spectroscopy, magnetic reso 
nance imaging, or both nuclear magnetic resonance Spec 
troscopy and magnetic resonance imaging. 
In a further aspect, the invention provides a pharmaceu 
tical composition which comprises a hyperpolarized noble 
gas dissolved in a physiologically compatible liquid carrier. 
In yet another aspect the present invention provides a 
method for Studying a property of a noble gas in a tissue. 
This method of the invention comprises: (a) hyperpolarizing 
a noble gas; (b) dissolving the hyperpolarized noble gas in 
a physiologically compatible liquid carrier to form a mix 
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ture; (c) contacting the tissue with the mixture from (b); and (d) Scanning the tissue by nuclear magnetic resonance, 
magnetic resonance imaging, or both, whereby the property 
of the noble gas in the tissue is Studied. 
In a further aspect, the invention provides a method for 
enhancing the relaxation time of a hyperpolarized noble gas 
in contact with a physiological fluid. This method com 
prises: (a) forming a hyperpolarized noble gas intermediate 
Solution by dissolving the hyperpolarized noble gas in a fluid 
in which the relaxation time of the noble gas is longer than 
the relaxation time of the noble gas in the physiological 
fluid; and (b) contacting the physiological fluid with the 
intermediate Solution. 
In yet a further aspect, the present invention provides a 
method for measuring a Signal transferred from at least one 
hyperpolarized noble gas atom to at least one non-noble gas 
NMR active nucleus, comprising: (a) contacting a non-noble 
gas NMR active nucleus with a hyperpolarized noble gas 
atom; (b) applying radiofrequency energy to the non-noble 
gas NMR active nucleus in a magnetic field; and (c) mea 
Suring the Signal transferred from the hyperpolarized noble 
gas atom to the non-noble gas NMR active nucleus using 
nuclear magnetic resonance Spectroscopy, magnetic reso 
nance imaging, or both. 
In a still further aspect, the invention provides a pulse 
Sequence for heteronuclear difference Spin polarization 
induced nuclear Overhauser effect (SPINOE) NMR of a 
System comprising at least one hyperpolarized noble gas 
atom and at least one non-noble gas NMR active nucleus, 
comprising: (a) at least one non-noble gas NMR active 
nucleus L/2 pulse; (b) a non-noble gas NMR active nucleus 
It pulse applied simultaneously with application of a noble 
gas It pulse; and (c) a non-noble gas NMR active nucleus C/2 
pulse. 
In an additional aspect, the invention provides an appa 
ratus for preparing a Solution of a hyperpolarized noble gas 
in a fluid, the apparatus comprising: 
a vessel for receiving the fluid; 
a reservoir for receiving the hyperpolarized noble gas, the 
reservoir communicating through a first shutoff Valve 
with the vessel, the reservoir being shaped to allow the 
reservoir to be cooled independently of the vessel; 
a gas inlet port communicating through a Second shutoff 
valve with the reservoir; and 
a means for withdrawing the fluid from the vessel inde 
pendently of the first and second shutoff valve. 
Other features, objects and advantages of the invention 
and its preferred embodiments will become apparent from 
the detailed description which follows. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1. A schematic is set forth of the experimental 
protocol used. Eighty percent of isotopically enriched 'Xe 
is polarized via Spin exchange with optically pumped 
rubidium atoms using previously described techniques. The 
Xenon is frozen at liquid nitrogen temperature in a Sidearm 
of a Sample tube in high magnetic field provided by a 
permanent magnet. The Xenon is then brought to the gas 
phase by warming and admitted to the Solution. 
FIG. 2. 'Xe NMR spectrum of a solution of 'Xe in 
DO 
FIGS. 3A and 3B. Conventional and optically polarized 
'Xe NMR spectra of xenon in blood acquired after inject 
ing 1 cc of Xenon/water mixture into 1 cc of concentrated red 
blood cells are set forth. 
FIG. 4. The time dependence of the integrals of the two 
peaks in a typical 'Xe NMR of 'Xe in blood is set forth. 
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FIGS. 5A and 5B. Intrinsic exchange of xenon between 
the extracellular and intracellular compartments of blood. 
FIG. 5A shows the initial equilibrium spectrum and the time 
dependent spectra following the selective inversion. FIG. 5B 
shows the time dependence of the Signal intensities. 
FIGS. 6A and 6B. Optically pumped 'Xe spectrum of 
Xenon delivered to blood in the INTRALIPID(R) Solution is 
provided (A). 2-dimensional 'Xe MR image laser 
polarized xenon in blood/INTRALIPID(R) (A, inset). A 'Xe 
spectrum acquired after mixing the xenon/FLUOSOLOR 
solution in whole blood (B). Compressed 'Xe NMR 
spectrum of xenon/FLUOSOL(R) solution in whole blood (B, 
inset). 
FIG. 7. Two-dimensional magnetic resonance image of 
'Xe dissolved in fresh human blood taken immediately 
after the blood is mixed with the saline Saturated by hyper 
polarized Xenon. The 128x64 images were taken by the 
Echo Planar Imaging (EPI) method on a Quest 4300 spec 
trometer. The diameter of the sample tube is 10 mm, and the 
Solution occupies a region of length of 20 mm. 
FIG. 8. Time dependence of the hyperpolarized 'Xe 
NMR signal observed in benzene solution after being con 
tacted with hyperpolarized Xenon. The main figure shows 
the data for partially deuterated benzene (25% CDH, 75% 
CD); the inset shows the data for normal benzene (CH). 
In the experiments represented by open circles, Xenon was 
admitted into benzene by opening the Xenon reservoir; the 
initial rise in Signal represents the penetration of Xenon into 
the Solvent. In the experiment represented by closed circles, 
the Xenon was mixed with the benzene by Shaking the 
Sample after opening the Xenon reservoir, So as to produce 
a uniform Saturated Solution. 'Xe Spin polarization was 
enhanced by optical pumping using circularly polarized light 
at 794.7 nm. Typically, 4x10" moles of enriched 'Xe 
were used in one experiment. The difference in the 'Xe 
Signal between benzene and deuterated benzene demon 
strates the effect of magnetic dipolar coupling between "H 
and 'Xe spins on the relaxation of the 'Xe. For the initial 
NOE experiments, the partially deuterated liquids were used 
in order to favor the effects of cross-relaxation over those 
contributing to H auto-relaxation. 'Xe NMR was per 
formed at 51 MHz on a Quest 4300 spectrometer using a 
home-built probe and a tipping angle of 3. 
FIG.9. Time dependence of the "H NMR signal observed 
after exposure of partially deuterated benzene (25% CDH, 
75% C.D.) to hyperpolarized 'Xe. The sample was 
exposed to Xenon at Zero magnetic field and was then 
inserted into the NMR probe within a few seconds. The 
initial rise of the "H signal is due to spin-lattice relaxation. 
The "H NMR signal exhibits a positive (O) or negative (()) 
NOE depending on the sign of the 'Xe polarizion. From 
the variation of the "H signal in the presence of unpolarized 
xenon (O), the "H T of the benzene-xenon solution is 
determined to be ~160s. Inset: Time dependence of the "H 
NMR signal after polarized 'Xe was dissolved in partially 
deuterated benzene. Prior to admitting the Xenon, the Sample 
was placed in the NMR magnet for approximately 10 
minutes to allow thermal equilibration of the H magneti 
Zation. After the Xenon reservoir was opened, the Sample 
was then Shaken to ensure efficient mixing of the Xenon and 
benzene. The Smooth lines represent a fit to the time 
dependent solution (J. H. Noggle, R. E. Schirmer, The 
Nuclear Overhauser Effect. Chemical Applications 
(Academic Press, New York-London- Toronto-Sidney-San 
Francisco, 1971)) of Eq. 1. 
(1) 
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yielding time constants of 120s and 1050s (O), and 140s and 
1020s (0). H NMR was performed at 185 MHz using a 
home-built probe and a tipping angle of 3. 
FIG. 10. Time-resolved, two-dimensional magnetic reso 
nance images of 'Xe dissolved in benzene, taken after the 
exposure of the benzene to hyperpolarized 'Xe. A Xe 
concentration gradient exists immediately after the Xe is 
admitted, evolving with time to a more uniform Solution. 
The 64 pixel by 128 pixel images were taken by the fast 
low-angle shot (FLASH) imaging method on a Quest 4300 
spectrometer, with a tipping angle of 3 for each of the 64 
Signal acquisitions. The frequency-encoding gradient was 
3.5 G/mm. The Step size of the phase-encoding gradient 
pulses, which were 500 us long, was 0.063 G/mm. The 
diameter of the Sample tube is 7 mm, and the Solution 
occupies a region of length 15 mm. 
FIG. 11. Time-resolved distribution of 'Xe magnetiza 
tion in partially deuterated benzene from MRI projection 
along the tube axis (Z). The sample was not shaken after 
Xenon was admitted to the benzene in order to prevent a 
uniform initial concentration. In the first image taken 47s 
after the admission of the Xenon gas to the Solution three 
regions may be distinguished. The intensity above the Solu 
tion level (above 18 mm) arises from 'Xe in the gas phase 
which is displaced from the dissolved 'Xe signal due to its 
different chemical shift. The decrease of the gas Signal above 
21 mm along the Z axis is due to the declining NMR 
Sensitivity beyond the radiofrequency coil, represented by 
circles in the Schematic. The Signal maximum at a position 
of 15.2 mm corresponds to the top of the Solution, arising 
from Xenon diffusing into the Solution from the gas phase. 
The Signal maximum at about 1.3 mm corresponds to the 
lower end of the tube. Thus, Xenon accumulates at the 
bottom of the sample tube first and a discernible xenon 
concentration gradient persists for up to 5 minutes. The 
concentration gradient results from natural convection due 
to density differences between the xenon solution and that of 
pure benzene, progressing ultimately to a uniform Saturated 
Xenon Solution. The imaging field gradient was 2.6 G/mm. 
FIG. 12. Two-dimensional magnetic resonance images of 
the NOE enhanced "H signals at 2 and 6 minutes after 
hyperpolarized Xenon was admitted to the Sample tube 
containing normal benzene. The enhancement images were 
obtained by Subtracting the equilibrium image shown, which 
is the average of four images taken after 25 minutes. The 
intensity Scale in the difference images has been magnified 
8-fold for clarity. The maximum NOE enhancement in the 2 
minute image is 0.05; that in the 6 minute image is 0.12. A 
perceptible gradient of the enhanced "H signal is observed in 
the 2 minute image, corresponding to the observed gradient 
in the Xenon concentration and the enhancement is found to 
be uniform in the 6 minute image when the Xenon concen 
tration gradient is diminished. The negative region in the 2 
minute image could be caused by expansion of the liquid 
phase as Xenon dissolves. The images were taken by the 
Echo Planar Imaging method (Mansfield, P., J. Phys. C 10, 
L55 (1977)) in 24 ms. The frequency-encoding gradient was 
3.15 G/mm, the phase-encoding gradient pulses were 0.14 
G/mm and 50 us long. The image dimension was 128x32, 
and the image was Zero-filled to 256x256 in data processing. 
The skew of the image is due to the inhomogeneity of the 
Static magnetic field. 
FIG. 13. Schematic diagram of the pulse Sequence used to 
obtain heteronuclear difference SPINOE spectra. The proton 
magnetization is Saturated first by a Series of JL/2 pulses and 
a Z-axis magnetic field gradient is applied in between the 
pulses to dephase the transverse components of the magne 
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tization for optimal Saturation. The It pulses helps to reduce 
the growth of proton Signal due to spin-lattice relaxations. A 
It pulse is also applied to the 'Xe resonance at the same 
time of the proton I pulses so that the 'Xe magnetization 
is inverted in Synchronization with the proton magnetiza 
tion. This synchronization ensures that the SPINOE signals 
will be accumulated during the entire mixing time. Both 
proton and Xenon at pulses are adiabatic pulses BIR4 of 1 mS 
in duration. 
FIGS. 14A and 14.B. (A) Proton spectra of 0.1 
p-pnitrotoluene Solution in perdeuterated benzene at thermal 
equilibrium; (B) SPINOE proton spectra of 0.1 M 
p-nitrotoluene Solution in perdeuterated benzene with posi 
tive and negative 'Xe spin polarization. The total mixing 
time is 2.1 S. 
FIG. 15. Proton spectra of 0.05 M C.-cyclodextrin solution 
in perdeuterated DMSO (dimethyl sulfoxide) at thermal 
equilibrium; 
FIG. 16. SPINOE spectrum of C-cyclodextrin in the 
presence of negatively poled 'Xe. 
FIG. 17. SPINOE spectrum of C-cyclodextrin in the 
presence of positively polarized 'Xe. The positive 'Xe 
polarization is defined to be along the thermal equilibrium 
polarization. The total mixing time is 1 S and two signals 
were acquired for each spectrum. 
FIG. 18. Schematic diagram showing the process used for 
in vivo imaging of hyperpolarized 'Xe in the rat. 
FIG. 19. A 'Xe Xenon spectrum representing an average 
of the sixth through the twelfth scan in a series of 'Xe 
Spectra taken over the thorax and abdomen areas following 
intravenous injection of a xenon/INTRALIPID(R) Solution in 
the rat. 
FIG. 20. Schematic diagram of the 'Xe imaging experi 
ment showing the timing of and relationship between the 
excitation pulse, slice Selection pulse, first and Second 
gradients and Signal detection. 
FIG. 21. Two dimensional 'Xe images taken at intervals 
of approximately 7 seconds. The images depict the 'Xe 
Signal intensity in the upper part of the rat's hind leg. 
FIG. 22. A representation of one possible apparatus to 
accomplish the mixing of a hyperpolarized noble gas with a 
fluid as contemplated by this invention. The apparatus has 
four main Subcomponents: a vessel for receiving the fluid 
10, a noble gas reservoir 20, a gas inlet port 40, and a means 
to remove the liquid from the vessel 60. The reservoir and 
the vessel are connected by means of a shutoff valve 30. 
Similarly, the reservoir and the gas inlet port are connected 
via a shutoff valve 50. 
DETAILED DESCRIPTION OF THE 
INVENTION AND PREFERRED 
EMBODIMENTS 
It has been discovered that when a hyperpolarized noble 
gas (e.g., 'Xe) is dissolved in liquid solvents, a time 
dependent departure of; e.g., the proton Spin polarization 
from its thermal equilibrium is observed. The variation of 
the magnetization, positive or negative depending on the 
Sign of the Spin polarization of the noble gas, is an unex 
pected manifestation of the nuclear Overhauser effect 
(NOE), a consequence of cross relaxation between the spins 
of the Solution protons and the dissolved hyperpolarized 
noble gas. Time-resolved magnetic resonance images of 
both nuclei, H and dissolved noble gas, in solution show 
that the proton magnetization is Selectively perturbed in 
regions containing the spin-polarized noble gas. Thus, it has 
now been determined that optical pumping and the nuclear 
Overhauser effect can effectively be used to transfer 
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enhanced polarization from hyperpolarized noble gas to 
Solution phase Species without requiring the need for radiof 
requency irradiation of the perturbing Spins, an effect which 
is denoted Spin Polarization Induced Nuclear Overhauser 
Effect (SPINOE). Thus, SPINOE can advantageously be 
used to enhance the sensitivity of NMR and, in turn, to better 
determine the primary Structure, conformation and local 
dynamic properties of the molecules in a liquid Solution. 
AS Such, in one a the present invention provides a method 
for analyzing a Sample containing an NMR active nucleus. 
This method comprises: (a) contacting the sample with a 
hyperpolarized noble gas; (b) Scanning the sample using 
nuclear magnetic resonance Spectroscopy, magnetic reso 
nance imaging, or both nuclear magnetic resonance Spec 
troScopy and magnetic resonance imaging, and (c) detecting 
the NMR active nucleus, wherein the NMR active nucleus 
is a nucleus other than a noble gas. 
The term “contacting” is used herein interchangeably with 
the following. combined with, added to, dissolved in, mixed 
with, passed over, flowed over, administered to, injected 
into, ingested by, etc. The Sample can be contacted with the 
hyperpolarized noble gas in a liquid, Solid or gas phase. 
Further, the Sample Studied may be a liquid, Solid, a com 
bination of a liquid and a Solid or the boundary between a 
Solid and a liquid. Prior to contacting the Sample with the 
hyperpolarized noble gas, it may be desirable to freeze the 
noble gas to preserve the hyperpolarization. Further, freez 
ing the gas in a magnetic field can preserve the hyperpolar 
ization for a period which is significantly longer than that 
obtained Simply by freezing the gas. For those noble gases 
which freeze at temperatures which are difficult to achieve, 
it is within the Scope of this invention to cool those gases to 
a temperature above their freezing point. This procedure is 
encompassed by the term “freezing.” Similar to that 
described above, Such cooling can also occur in the presence 
of a magnetic field. 
Once contacted with the noble gas, the Sample can be 
scanned using NMR, MRI or both. The sample is scanned to 
detect the effects of the hyperpolarized gas on NMR active 
nuclei within the sample. Any non-noble gas NMR active 
nucleus can be detected. As used herein, "NMR active 
nucleus' denotes those nuclei which have a nonzero Spin 
quantum number. Such NMR active nuclei include, but are 
not limited to, H, C, N, F, 'Si, P and combinations 
thereof In preferred embodiments, multiple NMR active 
nuclei are detected. By detecting the effects of the hyper 
polarized noble gas on the Sample, one can readily analyze 
the Structure, chemistry, Spatial distribution, etc. of the 
Sample. 
In another aspect, the present invention provides a method 
for analyzing a Sample which is based on the discovery that 
a noble gas can be combined with a fluid to form a mixture 
and, in turn, the mixture can be delivered to blood or other 
tissue while the noble gas still has a large off-equilibrium 
nuclear spin polarization. Thus, this method comprises: (a) 
combining a hyperpolarized noble gas with a fluid to form 
a mixture; (b) contacting the sample with the mixture; and 
(c) Scanning the sample, the noble gas or both the sample 
and the noble gas by nuclear magnetic resonance 
Spectroscopy, magnetic resonance imaging or both nuclear 
magnetic resonance SpectroScopy and magnetic resonance 
imaging. 
AS used herein, the term “fluid” includes, but is not 
limited to water, Saline, phosphate buffered Saline, aqueous 
buffer Solutions, fluorocarbons, fluorocarbon Solutions in 
water or organic Solvents, aqueous fluorocarbon emulsions, 
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lipids, Solutions of lipids organic Solvents, aqueous emul 
Sions of lipids, organic Solvents (e.g., DMSO, ethanol, etc.). 
"Aqueous' encompasses Solutions and emulsions prepared 
with HO, HO or HO. The terms “fluid,” “liquid” and 
“liquid carrier are used interchangeably herein. 
In preferred embodiments, the noble gas is Selected from 
the group consisting of Xenon, helium, neon, krypton and 
mixtures of these gases. In more preferred embodiments, the 
noble gas is Xenon and in particularly preferred 
embodiments, the noble gas is either 'Xe or 'Xe. In this 
method, it is desirable to predissolve the hyperpolarized 
noble gas in a fluid which can, for example, prolong its 
relaxation time when the hyperpolarized Xenon is in contact 
with physiological fluids. For instance, if the hyperpolarized 
gas is to be injected into blood, it is desirable to first 
pre-dissolve the hyperpolarized gas in a lipid, lipid Solution 
or lipid emulsion to form a mixture which, in turn, is injected 
into the blood. Also desirable is dissolving the hyperpolar 
ized noble gas in a fluorocarbon, fluorobon Solution or 
fluorocarbon emulsion. The means of making Such lipid and 
fluorocarbon formulations will be apparent to those of skill 
in the art. Moreover, it may be desirable to use a hyperpo 
larized noble gas to polarized a fluid which, in turn, is used 
as the contrasting agent or probe. For instance, it may be 
desirable to polarized water by combining it with a hyper 
polarized noble gas and, thereafter, use the polarized water 
as the contrasting agent or probe. It may also prove advan 
tageous to dissolve the noble gas in a liquid prior to 
hyperpolarizing the noble gas. 
In another aspect, the present invention provides a phar 
maceutical composition comprising a hyperpolarized noble 
gas dissolved in a physiologically compatible liquid carrier. 
In preferred embodiments, the liquid carrier is compatible 
with administration of the hyperpolarized gas by 
percutaneous, intravenous, oral, intraperitoneal, intramuscu 
lar or inhalation routes. In certain more preferred 
embodiments, the liquid carrier is appropriate for adminis 
tration to an organism via an intravenous route. 
AS noted above, the hyperpolarized noble gas is combined 
with a fluid or liquid carrier which is chemically, biologi 
cally or materially compatible with the Sample to be ana 
lyzed or, in Some instance, dissolves as much of the noble 
gas as possible. Fluids suitable for use in the methods of the 
present invention include, but are not limited to, water, 
Saline water, isotonic buffers, lipids, lipid emulsions, organic 
solvents, fluorocarbon blood substitutes and other medically 
Safe intravenous or oral media in which the noble gas 
relaxation time is Sufficiently long. 
In preferred embodiments, the fluid in which the noble gas 
is dissolved is a fluorocarbon or aqueous perfluorocarbon 
emulsion. Preferred species are perfluorocarbons including, 
but not limited to, perfluorodecalin, perfluoro-1,3- 
dimethylcyclohexane, perfluorohexane(s), perfluorohexyl 
iodide, perfluoro(methylcyclohexane), perfluoro 
(methylde calin), perfluoro-2-methyl-2-pentene, 
perfluorononane, perfluorooctane(s), perfluorobutylamine 
and perfluorotriethylamine. The only caveat to the use of 
perfluorocarbons is that, where it is desired to use fluoro 
carbons in vivo, the fluorocarbons must be compatible with 
the biological system under study. Those of skill in the art 
will readily be able to discern whether the fluorocarbon is 
compatible with the biological system. For in vitro 
applications, Such compatibility is desirable but is not essen 
tial. 
Particularly preferred fluorocarbons are those known in 
the art to be safe for in vivo administration. Of those safe for 
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in Vivo administration, perfluorocarbons which are useful as 
blood substitutes are the most preferred. Perfluorocarbons 
useful as blood substitutes are known in the art. (See, for 
example, Long, D. M., et al. in BLOOD SUBSTITUTES, 
Chang, T. M. S. and Geyer, R. D., Eds. Marcel Dekker, Inc. 
New York 1989, pp. 411-420, which is herein incorporated 
by reference.). Examples of perfluorocarbons used as blood 
substitutes include perfluorooctylbromide (PFOB), perfluo 
rtributylamine and perfluorodecalin. Fluorocarbons can be 
used as neat liquids, emulsions, or they can be dissolved in 
a Solvent or injection adjuvant prior to their use. 
Fluorocarbon emulsions can be formed with water, 
plasma, blood, bufferS or other aqueous constituents. Meth 
ods of producing pharmaceutically acceptable Solutions and 
emulsions are well know to those of skill in the art and any 
means known in the art for preparing these mixtures can be 
used to practice the instant invention. (See, Nairn, J. G., in 
Remington's Pharmaceutical Sciences, Vol. 17, Gennaro, A. 
R., Ed., Mack Publishing Co., Easton, PA, 1985, pp. 
1492–1517, which is incorporated herein by reference.). 
Fluids particularly preferred in practicing the present 
invention are commercially available blood Substitutes Such 
as PFB-1, PFB2 (Alliance Pharmaceutical Corp.) and 
FLUOSOL(R). FLUOSOL(R), an intravascular perfluorocar 
bon emulsion which is commercially available from Alpha 
Therapeutic Corporation (Los Angeles, Calif., U.S.A), is 
exemplary of a fluorocarbon blood substitute which can be 
used in the methods of the present invention. Other fluoro 
carbons and fluorocarbon formulations useful in practicing 
the invention will be apparent to those of skill in the art. 
In another embodiment, the noble gas is dissolved in a 
lipid, lipid solution or lipid emulsion. The term “lipid” refers 
to any oil or fatty acid derivative. The oil may be derived 
from vegetable, mineral or animal Sources. AS used herein, 
the term “lipid” also includes those lipids which are capable 
of forming a bilayer in aqueous medium, Such that a 
hydrophobic portion of the lipid material orients toward the 
bilayer while a hydrophilic portion orients toward the aque 
ouS phase. Hydrophilic characteristics derive from the pres 
ence of phosphate, carboxylic, Sulfato, amino, Sulfhydryl, 
nitro and other like groups. Hydrophobicity can be conferred 
by the inclusion of groups that include, but are not limited 
to, long chain Saturated and unsaturated aliphatic hydrocar 
bon groupS and Such groupS Substituted by one or more 
aromatic, cycloaliphatic or heterocyclic group(S). Preferred 
lipids are phosphoglycerides and Sphingolipids, representa 
tive examples of which include phosphatidylcholine, 
phosphatidyle thanolamine, phosphatidylserine, 
phosphatidylinositol, phosphatidic acid, palmitoyloleoyl 
phosphatidylcholine, ly Sophosphatidylcholine, 
ly Sophosphatidyl-e than olamine, 
dip ah mitoyl phosphatidylcho line, 
diole oyl phosphatidylcho line, di Stearoyl 
phosphatidylcholine or dilinoleoylphosphatidylcholine 
could be used. Other compounds lacking in phosphorus, 
Such as Sphingolipid and glycosphingolipid families, are 
also within the group designated as lipid. Additionally, the 
amphipathic lipids described above may be mixed with other 
lipids including triglycerides and Sterols. 
Particularly preferred in practicing this embodiment of the 
present invention is the use of a commercially available lipid 
preparation such as 10% or 20% INTRALIPID(R) (Clintec 
Nutrition, Deerfield, Ill., U.S.A.), or 10% or 20% LIPO 
SYNCR) II, or 10% or 20% LIPOSYNCR III. LIPOSYNCR) is an 
intravenous fat emulsion which is commercially available 
from Abbot Laboratories (Abbot Park, Ill., U.S.A.), and is 
exemplary of a lipid emulsion which can be used in the 
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methods of the present invention. Lipid emulsions are par 
ticularly useful because they dissolve the noble gases and, in 
addition, because the noble gases have long relaxation times 
in such lipids. Other lipids, lipid mixtures and fluids in 
general which are Suitable for use in accordance with the 
present invention will be apparent to those of Skill in the art. 
It should be noted that it is often desirable to add a 
deuterated or partially deuterated Solvent to the mixture. 
Moreover, intramuscular injection adjuvants, Such as 
DMSO, vitamin E, etc., can also be used as carriers of the 
noble gas. Many of these fluids are readily available from 
commercial Sources. Other compounds which are Solvents 
for noble gases and also have pharmaceutically acceptable 
or pharmacologically useful properties will be apparent to 
those of skill in the art. 
In certain preferred embodiments, the fluid into which the 
noble gas is dissolved will have the property of Specifically 
or Selectively targeting a specific organ or tissue within an 
organism. Many methods of achieving Such targeting are 
known in the art. For example, lipid vesicles (liposomes) are 
known to be rapidly Scavenged by the cells of the reticu 
loendothelial system (RES). Thus, in one embodiment, 
polarized noble gas is targeted to the RES by its incorpo 
ration into a liposome. Certain liposomes ("Stealth 
liposomes”) are known which avoid the cells of the RES and 
remain primarily intravascular over their period of in vivo 
residence. Thus, in another embodiment, the hyperpolarized 
noble gas is incorporated into a "Stealth lipoSome” and is 
used as an intravascular agent. Other liposomes for use in 
the present invention include temperature-Sensitive 
liposomes, target-Sensitive liposomes and pH-sensitive lipo 
Somes. Each of these liposomes is well known in the art. 
(See, Oku, N. LIPOSOMES, pp.24–33, in Polymeric Drugs 
and Drug Delivery System, Dunn, R. L., et al., Eds. ACS 
Symposium Series 469, American Chemical Society, 
Washington, D.C., 1991, which is herein incorporated by 
reference.). 
The use of molecules which have a chemical avidity for 
receptors on cell Surfaces to deliver pharmaceutical agents to 
those cells is well known in the art. It is within the scope of 
the instant invention to dissolve a noble gas in a fluid 
containing a molecule with avidity for Specific tissueS or 
cells and exploit this avidity to deliver the noble gas to the 
tissue or cells. Each of the above-detailed embodiments can 
be used both in vitro and in vivo. 
The above discussion regarding the use of liposomes and 
receptor-mediated targeting of polarized noble gases is 
intended to Serve as an example of methods and delivery 
vehicles which are useful in conjunction with the present 
invention. These examples are not intended to define or limit 
the invention or the embodiments of the invention wherein 
the noble gas is targeted to Specific tissues. 
Once formed, the noble gas/liquid mixture can be com 
bined with the Sample using a number of different techniques 
known to those of Skill in the art. For example, if the Sample 
is a mammalian organism or a portion thereof, the mixture 
can be administered to the organism by, for example, 
injection, inhalation or ingestion. More particularly, depend 
ing upon its intended use, the noble gas/liquid mixture can 
be injected into the tissue of interest (if clinically harmless), 
or intravascularly to be delivered to the tissue of choice. In 
addition, the noble gas/liquid mixture can be Swallowed or, 
alternatively, a noble gas/liquid aeroSol can be inhaled for 
certain medical imaging applications. Once the noble gas/ 
liquid mixture has been administered to the Sample, the 
Sample is Scanned by nuclear magnetic resonance and/or by 
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magnetic resonance imaging for purposes of molecular 
structural studies and/or spatial distribution. It should be 
noted that the noble gas/liquid mixture can be administered 
a Single time or, alternatively, on a continuous or quasi 
continuous basis. 
AS used herein the term "sample' encompasses diverse 
Structures and can include an organism. “Sample” also 
include organic monomers and polymers, inorganic mono 
merS and polymers, biopolymers including, but not limited 
to, oligopeptides, polypeptides, antibodies, proteins, 
oligonucleotides, polymers of ribonucleic acids (e.g., RNA, 
mRNA, tRNA) and deoxyribonucleic acids (DNA) 
including, but not limited to, chromosomes, genes and 
plasmids. Also encompassed within the term "sample” are 
carbohydrates, including oligosaccharides, polysaccharides, 
glycoproteins and mucopolysaccharides, lipids, blood, 
carbohydrates, catalysts, polymers, porous materials (e.g., 
Surfaces, chemical reactor beds, rockS present in oil 
reserves), etc. A “sample” can natively contain NMR active 
nuclei, NMR inactive nuclei or a combination of NMR 
active and NMR inactive nuclei. Using the methods of the 
present invention, one can readily analyze the Structure, 
chemistry, Spatial distribution, etc. of Such Samples. Other 
Samples which can be analyzed using the methods of the 
present invention will be readily apparent to those of skill in 
the art. 
As used herein, the term “organism” refers to life forms 
including, for example, animals, plants, microorganisms and 
fungi. Methods of the invention can be used with organisms 
which are either living or dead. The term “organism” also 
encompasses portions of organisms (e.g., organs, organ 
group(S), tissue(s), etc.) either in Situ or removed from the 
organism to which they are native. 
The term “organ” refers to individual functional compo 
nents of an organisms including heart, liver, lungs, blood, 
brain, muscle, etc. “Organ group’ as used herein, refers to 
cooperative organ Systems, for example, reticuloendothelial, 
central nervous, peripheral nervous, digestive, etc. AS used 
herein “tissue” means a cell or an aggregate of Similar cells 
including, for example, blood, bone, muscle, nerve, etc. That 
Some overlap exists between the Structures encompassed by 
the terms “organ,” “organ group, and “tissue' should be 
recognized; these terms are not intended to be mutually 
exclusive. 
AS used herein, the term “organic monomer' refers to a 
Small organic (i.e., carbon containing) molecule with a 
molecular weight typically falling within the range of from 
about 15 daltons to about 1000 daltons. Beyond a general 
adherence to the Stated molecular weight range, no limita 
tion on the Structure or functionality of these molecules is 
intended. This term encompasses both Synthetic and natural 
compounds. Further, an “organic monomer may also com 
prise one or more inorganic molecules Such as is found in, 
for example, organic chelates, chelating resins, organome 
tallic compounds and metalloporphyrins. 
Complementary to the term “organic monomer,” and 
Similar in definition, is the term “organic polymer which 
encompasses organic molecules of a molecular weight 
greater than about 1000 daltons. Both synthetic and natural 
compounds are defined by this term. Organic polymers may 
include materials. Such as, for example, engineering plastics, 
textile polymers and polymers with medical applications. 
AS used herein, the term “inorganic monomer refers to a 
Small inorganic molecule with a molecular weight typically 
falling within the range of from about 1 dalton to about 1000 
daltons. “Inorganic monomer complements the term 
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“organic monomer' and thus, encompasses molecules which 
do not incorporate carbon as part of their structure. Comple 
mentary to the term "inorganic monomer' and Similar in 
definition is the term “inorganic polymer” which defines 
inorganic molecules of a molecular weight greater than 1000 
daltons and encompasses both Synthetic and natural poly 
meric materials. 
The term “protein,” as used herein, has the meaning 
commonly given it in the art and includes, for example both 
Structural and functional (i.e., enzymes) proteins. “Protein’ 
includes both natural and Synthetic proteins produced or 
isolated by any means known in the art. Non-natural proteins 
are also encompassed by this term. Thus, for example, a 
protein may contain one or more mutations in the amino acid 
Sequence of its peptide backbone. Proteins may also beer 
unnatural groups added as probes or to modify protein 
characteristics. These groups may be added by chemical or 
microbial modification of the protein or one of its Subunits. 
Additional variations on the term “protein’ will be apparent 
to those of skill in the art. 
The term "oligopeptide,” as used herein, refers to a 
peptide which is made up of 2-10 amino acid units. 
“Polypeptide,” as used herein, refers to peptides containing 
greater than 10 amino acid Subunits. Both "oligopeptide' 
and “polypeptide' refer to both natural and Synthetic pep 
tides which can contain only natural amino acids, only 
unnatural amino acids, or a combination of natural and 
unnatural amino acids. 
AS used herein, the term "oligonucleotide' refers to 
Synthetic or natural nucleotide constructs made up of 2-20 
nucleic acids. The oligonucleotide may be composed of 
either ribonucleic acids, deoxyribonucleic acids or combi 
nations thereof “Oligonucleotides' can be made up of only 
natural nucleic acids, only unnatural nucleic acids or a 
combination of natural and unnatural nucleic acids. 
As used herein, the terms “ribonucleic acid,” “deoxyri 
bonucleic acid,” “chromosomes” and “genes' have the 
meaning normally given to them by those of skill in the art 
and also include modified analogs which may be produced 
by any means known in the art including, but not limited to, 
chemical Synthesis and microbial Synthesis. 
The term “carbohydrates,” as used herein, refers to both 
natural and Synthetic Saccharides, oligosaccharides, 
polysaccharides, glycoproteins and mucopolysaccharides. 
Any means known in the art to produce or isolate carbohy 
drates can be used to provide carbohydrates of use in 
practicing the instant invention. 
AS used herein, the term “noble gas” refers to a rare or 
inert gas which is a member of the Zero group of the periodic 
table. Noble gases suitable for use in the methods of the 
present invention include those having a nuclear Spin, i.e., a 
non-Zero nuclear Spin. Examples of Such noble gases 
include, but are not limited to, He, "Ne, Kr, 'Xe, Xe 
and combinations thereof In a preferred embodiment, the 
noble gas employed is 'Xe, 'Xe or He. Although these 
noble gases are generally preferred, other noble gases may 
be preferred in different applications because of their dif 
ferent physical, chemical association and magnetic reso 
nance properties. Additionally, in Some instances, it may be 
preferred to use a combination of noble gases, e.g., 'Xe and 
He. 
In another aspect, the present invention provides a method 
for Studying a property of a noble gas in a tissue. The method 
comprises: (a) hyperpolarizing a noble gas; (b) dissolving 
the hyperpolarized noble gas in a physiologically compatible 
liquid carrier to form a mixture; (c) contacting the tissue 
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with the mixture from (b); and (d) Scanning the tissue by 
nuclear magnetic resonance Spectroscopy, magnetic reso 
nance imaging, or both, whereby the property of the noble 
gas in the tissue is Studied. 
In this aspect of the invention, the tissue Studied may be 
any tissue of the organism. The tissue may be studied in Situ 
or removed from the organism to which it is native. In 
preferred embodiments of this aspect of the invention, the 
tissue Studied is a tissue of the central or peripheral nervous 
System. In particularly preferred embodiments, the tissue is 
a component of the central nervous System Such as the brain, 
Spinal cord, blood-brain barrier or cerebroSpinal fluid and 
the Studied property of the noble gas in the tissue may be 
either a functional or a structural property. 
As used herein, the term “property” encompasses NMR 
parameters, functional properties and structural properties. 
The term “NMR parameter” refers to frequency shift, chemi 
cal shift Scalar coupling, dipolar coupling, relaxation time 
(e.g. T., T. T., T., etc.). Both functional and structural 
properties can be derived from the NMR parameters of the 
System under observation. 
The term “functional property,’ as used herein, refers to 
the properties of a noble gas interacting with a tissue and 
includes properties Such as, but not limited to, the mecha 
nism of eXchange of the noble gas between the intracellular 
and extracellular compartments, the exchange rate of the 
noble gas between the intracellular and extracellular com 
partments of a tissue, the residence time of the noble gas in 
the intracellular or extracellular compartment the effect of 
the noble gas on the chemistry or metabolism of the cell and 
the concentration of the noble gas in the extracellular or 
intracellular compartment of the tissue. 
AS used herein, the term "structural property refers to the 
properties of a noble gas interacting with a tissue and 
includes properties Such as, but not limited to, the Spatial 
distribution of the noble gas within the intracellular or 
extracellular compartment of a tissue and the location and 
identity of sites which bind the noble gas within the intra 
cellular compartment, extracellular compartment or the 
membrane Separating the compartments. 
In one preferred embodiment, the property Studied is the 
mechanism of eXchange of the noble gas between the 
intracellular and extracellular compartments of a tissue. In 
another preferred embodiment, the tissue Studied is a tissue 
of the peripheral or central nervous System. In a more 
preferred embodiment, the property Studied is the mecha 
nism of noble gas exchange between the intracellular and 
extracellular compartments of a tissue of the central nervous 
System. 
In Still another aspect, the invention provides a method for 
enhancing the relaxation time of a hyperpolarized noble gas 
in contact with a physiological fluid. In this aspect, the 
method of the invention comprises: (a) forming a hyperpo 
larized noble gas intermediate Solution by dissolving the 
hyperpolarized noble gas in a fluid in which the relaxation 
time of the hyperpolarized noble gas is longer than the 
relaxation time of the noble gas in the physiological fluid; 
and (b) contacting the physiological fluid with the interme 
diate Solution. 
AS used herein, the term "physiological fluid’ encom 
passes the various intracellular and extracellular fluids 
which are found in an organism. Such physiological fluids 
include, but are not limited to, blood, plasma, lymph, 
cerebroSpinal fluid, bile, Saliva, gastric fluids, Vitreous 
humor, cytoplasm, etc. 
AS used herein, the term “relaxation time' refers to the 
time required for a nucleus which has undergone a transition 
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into a higher energy State to return to the energy State from 
which it was initially excited. Regarding bulk phenomena, 
the term “relaxation time” refers to the time required for a 
sample of nuclei, the Boltzmann distribution of which has 
been perturbed by the application of energy, to reestablish 
the Boltzmann distribution. The relaxation times are com 
monly denoted T and T.T. is referred to as the longitu 
dinal relaxation time and T is referred to as the transverse 
relaxation time. Other relaxation times of relevance include, 
but are not limited to T. (the paramagnetic contribution to 
the longitudinal relaxation rate) and T* (the transverse 
relaxation time including the effect of B inhomogeneity). 
AS used herein, the term “relaxation time” refers to the 
above-described relaxation times either together or in the 
alternative. Other relevant relaxation times will be apparent 
to those of Skill in the art. An exhaustive treatise on nuclear 
relaxation is available in Banci, L, et al. Nuclear and 
Electron Relaxation, VCR Weinheim, 1991, which is herein 
incorporated by reference. 
In a preferred embodiment of this aspect of the invention, 
the fluid into which the hyperpolarized noble gas is dis 
Solved is a fluorocarbon or lipid, as described above. In a 
more preferred embodiment, the fluid is an aqueous emul 
Sion of either a fluorocarbon or a lipid, or is an aqueous 
emulsion of a combination of a fluorocarbon and a lipid. 
In an additional aspect, the invention provides a method 
for measuring a signal transferred from a hyperpolarized 
noble gas atom to a non-noble gas NMR active nucleus, 
comprising: (a) contacting the non-noble gas NMR active 
nucleus with the hyperpolarized noble gas atom; (b) apply 
ing radiofrequency energy to the non-noble gas NMR active 
nucleus in a magnetic field; and (c) measuring the signal 
transferred from the hyperpolarized noble gas atom to the 
non-noble gas NMR active nucleus using nuclear magnetic 
resonance Spectroscopy, magnetic resonance imaging, or 
both. 
In preferred embodiments, the non-noble gas nucleus is a 
biologically relevant nucleus Such as, but not limited to, 'H, 
'C, N, P, etc. In a particularly preferred embodiment, 
the nucleus is a proton. 
In yet another aspect, the invention provides a pulse 
Sequence for heteronuclear difference Spin polarization 
induced nuclear Overhauser effect (SPINOE) NMR of a 
System comprising a hyperpolarized noble gas and a non 
noble gas NMR active nucleus. The pulse Sequence com 
prises: (a) a non-noble gas NMR active nucleus JL/2 pulse; 
(b) a non-noble gas NMR active nucleus It pulse applied 
Simultaneously with application of a noble gas. It pulse, and 
(c) a non-noble gas NMR active nucleus C/2 pulse. 
AS used herein, the term “non-noble gas It pulse' denotes 
a radiofrequency pulse, at the resonant frequency of a 
non-noble gas nucleus, which is delivered to the System and 
is of a duration Sufficient to rotate the bulk magnetization of 
the sample of non-noble gas nuclei by 180. Similarly, a 
"noble gas. It pulse' refers to a radiofrequency pulse Suffi 
cient to rotate the bulk magnetization of noble gas Sample by 
180. A “non-noble gas NMR active nucleus JL/2 pulse' will 
rotate the bulk magnetization of a sample of protons by 90. 
Means of delivering these pulses to the System under obser 
vation will be apparent to those of skill in the art. 
The pulse Sequence embodied in this aspect of the inven 
tion can be used to obtain information related to the transfer 
of polarization from a hyperpolarized noble gas to a non 
noble gas NMR active nucleuS Such as a proton. In a 
preferred embodiment, the pulse Sequence is used to Study 
regions of a structure that bind to or otherwise interact with 
15 
25 
35 
40 
45 
50 
55 
60 
65 
16 
the hyperpolarized noble gas. In other preferred 
embodiments, the pulse Sequence is used to Study a macro 
molecule Such as a protein, polysaccharide, polypeptide, 
oligonucleotide, or any other molecule which interacts with 
a hyperpolarized noble gas in a NMR or MRI discernable 
manner. In Still another preferred embodiment, the hyper 
polarized noble gas is dissolved in a fluid prior to its 
administration to a tissue. 
In another embodiment, the invention provides an appa 
ratus for preparing a Solution of a hyperpolarized noble gas. 
The apparatus comprises: a vessel for receiving the fluid; a 
reservoir for receiving the hyperpolarized noble gas, the 
reservoir communicating through a first shutoff Valve with 
the vessel, the reservoir being shaped to allow the reservoir 
to be cooled independently of the vessel; a gas inlet port 
communicating through a Second shutoff Valve with the 
reservoir; and a means for withdrawing the fluid from the 
vessel independently of the shutoff valve. 
The apparatus can be constructed of any material with the 
caveats that the material does not speed the relaxation of the 
hyperpolarized gas and must be capable of withstanding the 
temperatures necessary to freeze the noble gas and the 
temperature shifts between the temperature used to freeze 
the noble gas and room temperature or higher. Thus, the 
apparatus can be constructed of, for example, glass, pyrex, 
metal or plastic. 
The limitations on the shape and size of the components 
are minimal. The only essential limitation being that the 
noble gas reservoir is capable of being cooled Separately 
from the fluid vessel. Thus, it is within the scope of the 
invention to have a reservoir which is a Side-arm, flask or 
other receptacle pendent off of the fluid vessel. The reservoir 
may also be separable from the rest of the apparatus by 
means of a joining means Such as, for example, tubing, 
hoses, ground-glass joints, ball-and-Socket joints, or any 
other joining means known to those of skill in the art. When 
large Volumes of gas and/or fluid are to be used, it is 
particularly preferred that the apparatus be composed of 
Separable components (i.e., reservoir and vessel) which can 
be assembled and disassembled as need be to facilitate the 
purpose of the apparatus. 
The shutoff valves between the main components of the 
apparatus comprise any means of reversibly Separating two 
attached vessels known in the art. Thus, it is within the Scope 
of the invention to use a Stopcock, Septum, Valve, check 
Valve, pressure- release valve, etc. Similarly, the means to 
remove the fluid from the vessel may comprise any means 
known in the art to reversibly Seal a vessel. These include, 
but are not limited to, Stopcocks, Septa, membranes, break 
Seals, caps, plugs, break-Seals, etc. 
In a preferred embodiment, the apparatus further com 
prises a means for freezing the hyperpolarized noble gas in 
the reservoir for receiving the hyperpolarized noble gas. The 
means to freeze the gas may consist of any means known in 
the art for attaining temperature Sufficiently low to freeze a 
noble gas. These include, but are not limited to, liquid gases, 
circulating baths and refrigeration units. 
In another preferred embodiment, the apparatus further 
comprises a means for applying a magnetic field to the 
frozen hyperpolarized noble gas to preserve the hyperpolar 
ization prior to forming the mixture between the hyperpo 
larized gas and the fluid. Any means known in the art for 
applying a magnetic field will be useful in the instant 
invention. These include, but are not limited to, permanent 
magnets, electromagnets, Superconducting magnets and the 
magnet in an NMR spectrometer or imaging device. 
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AS noted above, the noble gas used in the methods of the 
present invention is hyperpolarized relative to its normal 
Boltzmann polarization. Noble gases can be hyperpolarized 
for use in accordance with the present invention through any 
of various means known to and used by those of skill in the 
art. Such methods include, but are not limited to, Spin 
eXchange interactions with optically pumped alkali metal 
Vapor and direct pumping by a metastable State. It will be 
readily apparent to those of Skill in the art that other methods 
can also be used to hyperpolarized the noble gases used in 
the present invention. In a preferred embodiment, optical 
pumping using circularly polarized light is used to produce 
a hyperpolarized gas. 
The term “optical pumping generally refers to the redis 
tribution of atoms among their fine- or hyperfine-Structure 
levels by means of light. The light can be circularly 
polarized, anisotropic, filtered or amplitude-modulated. In 
preferred embodiments, the light is circularly polarized 
Using relatively simple techniques known to those of skill in 
the art, it is possible to produce useful polarization of atoms, 
nuclei and electrons. For example, See, Carver, T. R., 
Science, 141(3581):599–608 (1963), for a detailed review of 
optical pumping. In addition, the details of an optical 
pumping apparatus Suitable for use in accordance with the 
present invention are described, for example, by Raftery, et 
al., Phys. Chem., 97: 1649 (1993); and Song, et al., J. 
Magnet. Res. 115: 127-130 (1995). The teachings of the 
above-cited references are incorporated herein by reference. 
The optical pumping and spin-exchange can be performed 
in the absence of an applied magnetic field, but are prefer 
ably performed using modest fields of about 1 G or larger. 
Pumping in the NMR magnet bore at fields of several Tesla 
is also possible. The maximum steady State nuclear polar 
ization achievable depends on the time constant character 
izing the Spin exchange with the alkali metal and the time 
constant characterizing the relaxation (T) due, for example, 
to contact with the Surfaces of the pumping cell. For 
instance, with 'Xe, T=20 min, polarizations of 20–40% 
are quite practicable, and polarizations of 90% or more 
should be attainable. 
Hyperpolarizing noble gases through spin exchange with 
an optically pumped alkali-metal vapor starts with the 
irradiation of the alkali-metal vapor with circularly polarized 
light at the wavelength of the first principal (D) resonance 
of the alkali metal (e.g., 795 nm for Rb). The S ground 
state atoms are thus excited to the P2 state and Subse 
quently decay back to the ground State. If performed in a 
modest (10 Gauss) magnetic field aligned along the axis of 
incident Dilight, this cycling of atoms between the ground 
and first excited States leads to nearly 100% polarization of 
the atoms. This polarization is carried mostly by the lone 
Valence electron characteristic of all alkali metals; this 
essentially means that all of these electrons have their spin 
either aligned or anti-aligned to the magnetic field depend 
ing upon the helicity (right- or left-handed circular polar 
ization State) of the pumping light. If a noble gas with 
non-Zero nuclear Spin is also present, the alkali-metal atoms 
can undergo collisions with the noble gas atoms in which the 
polarization of the Valence electrons is transferred to the 
noble-gas nuclei through a mutual spin flip. This spin 
eXchange results from the Fermi-contact hyperfine interac 
tion between the electron and the noble-gas nucleus. By 
maintaining the alkali-metal polarization at nearly 100% 
with the pumping light, large non-equilibrium polarizations 
(5%-80%) are currently achievable in large quantities of a 
variety of noble gases through this spin-exchange process. 
For example, one currently available Titanium:Sapphire 
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laser can theoretically provide 1 g/hr (200 cc-atm/hr) of 
highly polarized 'Xe. Even more product is expected from 
the use of modern diode array laserS. 
The alkali metals capable of acting as Spin exchange 
partners in optically pumped Systems include any of the 
alkali metals. Examples of alkali metals Suitable for use in 
this hyperpolarization technique include, but are not limited 
to, 'Na, KRb, 7.Rb and "Cs. In a presently preferred 
embodiment, Rb and "Rb are the alkali metal isotopes 
employed. 
In addition to optical pumping, the noble gas may be 
hyperpolarized using metastability exchange. The technique 
of metastability exchange involves direct optical pumping 
of, for example, He, without need for an alkali metal 
intermediary. The method of metastability exchange usually 
involves the excitation of ground state. He atoms (1'So) to 
a metastable state (2S,) by weak radio frequency discharge. 
The 2S, atoms are then optically pumped using circularly 
polarized light having a wavelength of 1.08 um in the case 
of He. The light drives transitions up to the 2P states, 
producing high polarizations in the metastable State to which 
the 2P atoms then decay. The polarization of the 2S, states 
is rapidly transferred to the ground State through metasta 
bility exchange collisions between metastable and ground 
State atoms. Metastability exchange optical pumping will 
work in the same low magnetic fields in which Spin 
eXchange pumping works. Similar polarizations are 
achievable, but generally at lower pressures, e.g., about 
0-10 Torr. 
Prior to and independent of hypolarization, further 
enhancement of the noble gas magnetic resonance Signal can 
be obtained by increasing the proportion of the NMR active 
isotope in each noble gas to a level above the natural 
abundance of Such imageable isotopes in the noble gas. For 
instance, in the case of 'Xe, which has a natural isotopic 
abundance of about 26%, the enhancement can amount a 
factor of about four for a gas which is enriched to 100% 
'Xe. Thus, although hyperpolarization plays a much larger 
role in Signal enhancement, isotopic enrichment can provide 
a Significant contribution to the ultimate efficacy of the 
present invention. 
In the methods of the present invention, the hyperpolar 
ized noble gas, e.g., 'Xe, can be delivered in gas, liquid or 
Solid phases. High preSSure noble gas can be conveniently 
obtained by first freezing into a Small Volume in the mag 
netic field followed by warring up. The noble gas is then 
combined with a fluid to form a mixture. Such a mixture can 
be formed, for example, by Vigorous shaking to equilibrate 
quickly the noble gas in the liquid, or by other efficient 
means of gas/liquid mixing which are known to and used by 
those of skill in the art. Alternatively, porous membranes or 
other devices known to those of skill in the art can be used 
to Saturate the Solution with the noble gas, provided they do 
not significantly decrease the relaxation time of the noble 
gas. It should be noted that the freezing of the hyperpolar 
ized noble gas also serves to purify the noble gas, e.g., to 
remove or Separate out the toxic alkali metal used in the 
hyperpolarization, and to prolong the hyperpolarization of 
the noble gas during Storage or Shipping. 
In the methods of the present invention, magnetic reso 
nance Spectroscopy and/or magnetic resonance imaging is 
used to detect a parameter which can be used to analyze, 
characterize or image a Sample or a portion thereof. Param 
eters of the Sample, the hyperpolarized noble gas or the 
System comprising the Sample and the hyperpolarized noble 
gas, which are useful for Such purposes include, but are not 
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limited to, chemical shift, T relaxation, T. relaxation and 
T. relaxation. In a preferred embodiment, multiple param 
eters are detected. In addition, multiple techniques can be 
employed in the methods of the present invention to collect 
and manipulate nuclear magnetic resonance data. Such 
methods include, but are not limited to, one-dimensional and 
multi-dimensional Spectroscopy, Fourier imaging, planar 
imaging, echo-planar imaging (EPI), projection 
reconstruction imaging, spin-Warp Fourier imaging, gradient 
recalled acquisition in the steady State (GRASS) imaging 
also known as fast low angle shot (FLASH) imaging, and 
hybrid imaging. For imaging purposes, preferred methods 
include the FLASH or GRASS imaging method and the EPI 
method because of their capacity to generate images through 
fast data acquisition, thereby conserving polarization of the 
noble gas. 
The methods of the present invention can be used for a 
myriad of diverse applications including, but not limited to, 
tissue perfusion quantitation, longer residence time imaging 
of air space; new proton contrast agent, new probe of 
pathophysiology; new application of NMR to gastrointesti 
nal clinical medicine; new non-toxic intravascular MRI 
angiography contrast agent; and protein Structure elucida 
tion by polarization transfer to protons or other nuclei in the 
molecule. In addition, the noble gas, when dissolved in a 
physiologically acceptable carrier can be utilized to Study 
lung air-space anatomy, tissue perfusion and MRI angiog 
raphy. Moreover, within the context of the methods dis 
closed herein, the present invention also has the following 
advantages. In general, hyperpolarized noble gas NMR can 
be used as an alternative to the imaging techniques that make 
use of radioactive isotopes, such as 'Xe and Xe. The 
advantages of MRI of hyperpolarized noble gases are the 
Zero radiation dose absorption by the patient and, in 
addition, a much better spatial resolution. In addition, NMR 
of noble gases are useful for brain Studies. Specifically, 
magnetic resonance imaging of a hyperpolarized noble gas 
enables better detection of central nervous System perfusion 
and, thus, it is useful as a tool for diagnosis of Stroke and as 
a flow Specific tool for functional imaging. Those of skill in 
the art will readily appreciate that the methods of the present 
invention are useful for a variety of other purposes as well. 
Those of skill in the art will readily appreciate that the 
noble gas is preferably maintained in a System which is 
Substantially Sealed to prevent loSS to the atmosphere. 
Typically, a Sealed containment apparatus will include a 
noble gas Source, Such as a gas canister or compressed gas 
tank conduits to and away from a Sample, as well as recovery 
apparatus. Moreover, a hyperpolarized noble gas may be 
Stored for extended periods of time in a hyperpolarized State. 
Storage Systems capable of cryogenic Storage of a hyperpo 
larized noble gas are preferably able to maintain tempera 
tures Such that noble gas is Stored in frozen State. For 
instance, frozen 'Xe can be reasonably maintained at fields 
of 2500 Gauss at temperatures ranging from 4.2 K. (liquid 
helium temperature), for which T, is about a million Sec 
onds (10 days), to 77 K. (liquid nitrogen temperature), for 
which T, is about 10 thousand seconds. The fields necessary 
here may be provided by a permanent magnet, a larger 
electromagnet or a Superconducting magnet. Those of Skill 
in the art will readily appreciate that a noble gas which has 
been hyperpolarized by Spin exchange with an alkali metal 
may be stored either before or after removal of any alkai 
metal used in Spin exchange hyperpolarization techniques. 
In all cases in which rubidium or other alkali metal would 
interfere with the behavior of the system, the alkali metal is 
removed before introduction of the noble gas to the Sample 
using techniques known to and used by those of Skill in the 
art. 
1O 
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The invention will be described in greater detail by way 
of Specific examples. The following examples are offered for 
illustrative purposes, and are intended neither to limit or 
define the invention in any manner. 
EXAMPLES 
Materials and Methods 
The following general materials and methods were used 
in the examples described below. 
The design of the Shaker used in the dissolution Stage for 
xenon mixing and delivery is illustrated in FIG. 1. The 
Shaker has a Small Sidearm which can be isolated from the 
main Volume by a Stopcock. The Shaker is charged with a 
Sample of either normal abundance or isotopically enriched 
xenon (80% 'Xe, EG&G Mound, Miamisburg, Ohio, 
U.S.A). Laser polarization is performed prior to admitting 
the xenon to the shaker. Briefly, approximately 5x10" mol 
of 80% isotopically enriched 'Xe was optically pumped in 
a 30 cc cylindrical glass pumping cell (diameter s30 mm). 
Before optical pumping, the cell was cleaned and coated 
with SURFASILOR (Pierce Chemical Co., Florence, Mass., 
U.S.A); the cell was then evacuated to 10 torr and loaded 
with one drop of melted rubidium metal in a dry nitrogen 
environment. Optical pumping was performed with a 1.3 W 
continuous-wave Ti:sapphire laser (794.7 nm) for 20-30 
min, and the temperature of the cell was maintained at 
60-80 C. by a temperature-controlled nitrogen gas Stream. 
Typically, the apparatus produces Xenon polarization levels 
in the range of 5-10%. 
Following laser polarization, the polarized 'Xe is frozen 
at liquid nitrogen temperatures in the Sidearm in a magnetic 
field of approximately 50 mT provided by a small permanent 
magnet. The magnetic field is used in the freezing Stage to 
prevent the decay of Xenon polarization. The Xenon is 
Sublimated and then admitted into the Solution. The Small 
Size of the Shaker allows for the accumulation of Several 
atmospheres of Xenon pressure which aids in increasing the 
Xenon concentration in the Solution. During the dissolution 
procedure, the vessel is vigorously shaken to help dissolve 
the Xenon gas. The resulting Xenon Solution is extracted with 
a Syringe through a high-pressure rubber Septum. In those 
examples below wherein a solution NMR study is performed 
on an in vitro Sample, the Xenon is immediately injected into 
an NMR tube which contains the sample to be studied. The 
loSS of polarization during the injection procedure was found 
to be insignificant. 
Example 1 
This example describes the 'Xe NMR of a sample of 
hyperpolarized 'Xe dissolved in aqueous saline. The T of 
Xenon was measured in both HO Saline and DO/Saline. 
In an NMR tube open to the atmosphere were combined 
saline and hyperpolarized 'Xe. The saline used had a NaCl 
concentration of 0.9% by weight. 'Xe was dissolved in 
Saline as described in the materials and methods Section 
above. Xenon has a low solubility in Saline, with an Ostwald 
coefficient of only 0.0926 (the standard temperature and 
preSSure Volume of Xenon dissolved in 1 liter of liquid at 1 
atmosphere of gas pressure; 1 atm=101.3 kPa). In HO/ 
saline, the T of xenon is quite long (66 s at 9.4T). The 
'Xe NMR spectrum of a solution of 'Xe in DO saline 
is displayed in FIG. 2. In saline made with DO, the T of 
xenon is s1000 s. Thus, the shorter T of xenon in HO/ 
Saline is due to dipolar couplings between the hyperpolar 
ized Xenon electrons and the proton nuclear Spins. 
Example 1 demonstrated the acquisition and characteris 
tics of 'Xe spectra of hyperpolarized xenon dissolved in 
aqueous Solution. 
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Example 2 
This example demonstrates the use of xenon NMR to 
Study the partition of Xenon between the intracellular and 
extracellular compartments in a Sample of human blood. The 
NMR of xenon in human blood was measured using both 
hyperpolarized and unpolarized Xenon. 
2.1 Materials and Methods 
A Sample of human blood was prepared by allowing fresh 
blood from a volunteer to settle for a few hours and 
Subsequently decanting off a portion of the plasma. The 
portion removed accounted for approximately 30% of the 
total volume of the blood sample. Following removal of a 
portion of the plasma, Xenon Saturated Saline (1 mL) was 
injected into the red blood cell (RBC) sample (1 mL) and the 
'Xe NMR was measured. The NMR spectra were mea 
sured on a Bruker AM-400 spectrometer. 
2.2 Results 
The NMR spectrum of non-polarized xenon was mea 
sured in an RBC sample (FIG. 3A). Considerable signal 
averaging was required in order to obtain a Spectrum with an 
acceptable Signal-to-noise ratio. The spectrum was acquired 
over 1.5 h and is the product of 520 scans. In marked 
contrast, a Spectrum with an excellent Signal-to-noise ratio 
was obtained following one scan when laser-polarized 'Xe 
was used (FIG. 3B). The signal enhancement obtained 
through using laser-polarized 'Xe, rather than non 
polarized 'Xe, was estimated to be approximately 3 orders 
of magnitude. 
The NMR spectra of both the laser-polarized and non 
polarized 'Xe in the RBC sample display two peaks; 216 
ppm and 192 ppm. The peak at 216 ppm arises from 'Xe 
which has diffused into the RBC. The peak at 192 ppm arises 
from the 'Xe which remains extracellular and is in the 
Saline/plasma mixture. The Significant difference between 
the Xenon chemical shift in the RBC and that in the Saline/ 
plasma is primarily due to the Xenon binding to hemoglobin. 
Thus, through the use of laser polarized Xenon it is 
possible to rapidly distinguish between intracellular and 
extracellular populations of 'Xe. Further, the significantly 
improved signal-to-noise ratio obtained in Spectra measured 
on samples containing laser polarized 'Xe NMR spectra 
allows the real time observation of the dynamics of the 
transfer of the Xenon from the Saline/plasma mixture into the 
RBC. 
Example 3 
Example 3 illustrates the use of NMR spectroscopy to 
observe the dynamics of the mixing of laser polarized 'Xe 
between the intracellular and extracellular compartments of 
a Sample consisting of red blood cells and plasma. 
3.1. Materials and Methods 
A Sample of laser polarized Xenon in Saline and a RBC 
Sample were prepared as described in Examples 1 and 2, 
respectively. By using short of pulses of Small tipping angle, 
'Xe NMR spectra were acquired as a function of time after 
injection of the xenon/saline mixture into the blood. NMR 
spectra were measured on a Bruker AM-400 spectrometer. 
3.2 Results 
The results of this experiment are illustrated in FIG. 4. In 
FIG. 4, the main figure shows the time dependence of the 
Xenon Signal in the RBC and in the Saline/plasma, normal 
ized by the total signal. The initial rise of the RBC signal and 
decrease in the Saline/plasma Signal indicates the transfer of 
xenon from the saline/plasma water mixture to the RBC 
during the mixing. Within the first second, the rise in the 
RBC signal and the reduction of the Saline/plasma Signal 
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describe the dynamic process of Xenon entering the RBC 
from the Saline/plasma during mixing. The time dependence 
of both the RBC and Saline/plasma Signals during the mixing 
process can be described by an exponential function of the 
form: 
where A and B are constants and the time constant (T) for 
this function was estimated to be about 200 ms. 
The signal increase (about 1 Sec) is probably due to Xenon 
rich blood dripping from the walls of the sample tube into 
the detection coil after Vigorous mixing. The Xenon transfer 
from the water to the red blood cells is evident. The 
timescale for the process is 170+30 ms. When 1 cc of saline 
water is mixed with 1 cc of red blood cells, the equilibrium 
distribution of the integral of the two peaks is approximately 
50%. Remarkably, the two peaks decay with the same rate 
constant (about 5 Seconds). Spin-lattice relaxation time of 
xenon in blood measured with conventional NMR yielded 
two different decay rates for the 2 peaks. This is probably an 
artifact associated with the settling of the red blood cells 
during the 12 or more hours of data acquisition required for 
the conventional experiments. After Separation of the eryth 
rocytes from the plasma, the Xenon exchange between the 
two compartments is very inefficient, and two different 
relaxation times are observed. When the red blood cells and 
the plasma are mixed, the exchange is fast enough to yield 
the same T for the two peaks. The value for the exchange 
rate we have measured is consistent with this model. AS the 
experiments have been performed in a Sample tube open to 
air, an additional contribution to the decay of the Signal may 
be due to Xenon transfer to the air. Such mechanism would 
not play a role when the Solution is administered intravas 
cularly to tissues. 
The inset in FIG. 4 displays the time dependence of the 
integrated Xenon signal from both peaks in the Spectra. From 
the decay starting after 2 Seconds, the T of the two 
components was found to be approximately 5.0 Seconds. 
The initial rise in the total Xenon Signal intensity during the 
first Second, following the Vigorous injection and mixing of 
the Xenon/Saline Solution, was most likely caused by Xenon 
containing blood/plasma/Saline mixture descending from the 
walls of the Sample tube into the region of the detection coil. 
Because the Sample was unlikely to be intimately mixed and 
equilibrated at the start of the NMR measurements, the data 
acquired in the above-described example reflect primarily 
the Xenon mixing process between the RBC and the Saline/ 
plasma. 
This example illustrates the feasibility of using the tech 
niques of the present invention to Study the dynamics of 
noble gas exchange between the intracellular and extracel 
lular compartments of a tissue. 
Example 4 
Example 4 describes the determination, using NMR 
Spectroscopy, of the intrinsic Xenon eXchange rate between 
the RBC and the saline/plasma. 
4.1. Materials and Methods 
A Sample of laser polarized Xenon in Saline and a RBC 
Sample were prepared as described in Examples 1 and 2, 
respectively. By using short of pulses of Small tipping angle, 
'Xe NMR spectra were acquired as a function of time after 
injection of the xenon/saline mixture into the blood. NMR 
Spectra were measured on a CMX Infinity spectrometer 
(Chemamagnetics-Otsuka Electronics, Fort Collins, Colo., 
U.S.A.) at a magnetic field of 4.3 Tesla. 
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4.2 Results 
The Xenon eXchange rate between the extracellular and intracellular compartments of a RBC/Saline/plasma Sample 
was measured by Selectively inverting the Xenon Saline/ 
plasma NMR line and observing the recovery of the two 
Signals. The Selective inversion was achieved by an 
amplitude-modulated Gaussian pulse of 1 mS duration cen 
tered at the frequency of the Saline/plasma Signal. This pulse 
also reduced the absolute signal intensities for the RBC and 
Saline/plasma peaks by about 50%. A field gradient pulse of 
1 mS was applied after the inversion pulse to dephase any 
components of the transverse magnetization. After the inver 
Sion pulse, Xenon spectra were taken at fixed time intervals 
using a Small tipping angle (20). Following the addition of 
the xenon/saline solution into the RBC sample, a delay of 3 
Seconds before the application of the inversion pulse insured 
that the xenon/RBC system was well mixed and equili 
brated. The results of the experiment are displayed graphi 
cally in FIG. 5A and FIG. 5B. 
FIG. 5A shows the initial equilibrium spectrum 13 ms 
before the application of the inversion pulse and three of a 
Series of Spectra which were measured after the Selective 
inversion pulse. The exchange of xenon from the RBC to the 
Saline/plasma is shown by the increase in amplitude of the 
Saline/plasma Signal and the corresponding reduction in the 
amplitude of the RBC signal. The time dependence of the 
signals, Sr. and S. can be described by the following 
equations: 
RBC (3) SpR = (SEP? + S. +S. exp(-i), RBC F (SRBC it. + to pt-. 
pi (4) Soi = (Sp?, +S, p - Sex (-), pl = (SRBC to expt 
pi RBC (5) S =S A - 
9 RBC RBC + pt pi RBC + pt 
where tric and t, are residence time constants for xenon in 
the RBC and Saline/plasma, and 1?t=1/tre+1?t, Sr. 
and S., are the initial intensities for the RBC and the plasma?saline components, respectively, immediately after 
the inversion pulse. The effect of the spin-lattice relaxation 
is neglected since t-T, making Srps, a constant during the eXchange process. 
The time dependence of the difference of the two signals, 
AS=S-S is shown in FIG. 5B. From an exponential 
fit, it was determined that T=12.0+1 ms. The reduction of the 
Signals due to the finite tipping angle was taken into account. 
Given the constraint on ti?t from the ratio of the signals 
at equilibrium, tro-20.4+2 ms, T=29.1+2 ms were 
obtained. The time Scale for the diffusion of Xenon (t= 
20.4 ms) corresponded to the time for the diffusion of xenon 
over a distance of 11 um (a diffusion constant of 10cm/s 
was assumed). This distance is slightly larger than the 
characteristic dimension of the RBC. The Xenon T, was 
found to be longer than that for water molecules, which was 
determined to be 12+2 ms at room temperature, Herbst, M. 
D., et al., Am. J. Physiol., 256: C1097-Co (1989). 
The above example demonstrates that data relevant to the 
dynamics of the interaction between laser polarized Xenon 
and its environment (e.g., a mixture of red blood cells and 
plasma) are accessible using NMR spectroscopy. 
Example 5 
This example illustrates the preparation and NMR prop 
erties of a vehicle for xenon delivery which consists of a 
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mixture of Xenon and an aqueous Suspension of lipid 
vesicles. An efficient method is provided for delivery of 
optically polarized Xenon to the vascular System in order to 
observe the xenon-129 NMR signal before the xenon polar 
ization has decayed. Specifically, the hyperpolarized gas is 
pre-dissolved in Solutions where the Xenon has a long 
spin-lattice relaxation time and, thereafter, the Xenon/ 
Solution mixture is administered to the blood. 
5.1 Materials and Methods 
A solution of hyperpolarized xenon in INTRALIPID(R) 
was prepared in the same manner as described for the Saline 
Solution of hyperpolarized Xenon, however, the Shaker was 
charged with INTRALIPID(R) rather than saline. 
INTRALIPID(R) Solutions consist of aqueous suspensions of 
lipid vesicles of approximately 0.1 um in diameter, which 
are well tolerated in Vivo and are used clinically as nutrient 
supplements. Commercially available 20% INTRALIPID(R) 
Solution (Pharmacia, Uppsala, Sweden) is approved by the 
U.S. Food and Drug Administration for use in humans. 
Importantly, Xenon has an approximately 4-fold greater 
solubility in INTRALIPID(R) than in saline. The 
INTRALIPID(R) Solution was charged with laser polarized 
'Xe and an aliquot (1 mL) of this solution was added to 
human blood (1 mL). The spectra were obtained on a Bruker 
AM-400 spectrometer. The 128x64 image was obtained by 
the Echo Planar Imaging method on a Quest 4300 (Nalorac 
Cryogenics, Martinez, Calif., U.S.A.) spectrometer. 
5.2 Results 
The xenon T in the INTRALIPID(R) solution was mea 
sured to be 40+3s. The spectrum of the laser polarized 
Xenon, delivered to blood as an Intralipid Solution, is shown 
in FIG. 6A. The predominant feature of the spectrum is a 
peak at 194 ppm, which corresponds to the xenon in the pure 
Intralipid solution. Only a small signal is observed at 216 
ppm, the Signal corresponding to Xenon in the RBC (i.e., 
intracellular). The ratio of the peak corresponding to Xenon 
in the INTRALIPID(R) solution and the peak from the 
intracellular Xenon is approximately 6:1. This result is 
consistent with a higher affinity of the xenon for the lipids 
and a correspondingly inefficient transfer into the RBC. The 
T decay time of the Signal at 194 ppm was measured to be 
16 S, a factor approximately 3-fold larger than the corre 
sponding decay time for Xenon in the Saline water/blood 
mixture. The 'Xe signal was so strong in this sample as to 
allow the direct imaging of the Xenon distribution in the 
mixture. The acquired image is displayed in FIG. 6A (inset). 
Xenon in blood can be utilized to Study lung air-space 
anatomy, tissue perfusion and NMR angiography. In 
general, hyperpolarized xenon NMR would be an alternative 
to the imaging techniques that make use of radioactive 
isotopes of xenon, such as 'Xe and 'Xe. The advantages 
of MRI of hyperpolarized xenon are the Zero ionizing 
radiation dose absorption by the patient and a potentially 
much better spatial resolution. NMR of xenon may also 
prove useful for brain Studies. Specifically, magnetic reso 
nance imaging of hyperpolarized Xenon would enable better 
detection of central nervous System perfusion and thus be a 
tool for diagnosis of Stroke and also a flow specific tool for 
functional imaging. 
This example demonstrates the preparation and the prop 
erties of Solutions of hyperpolarized Xenon in lipids. Also 
demonstrated is the principle that lipid Solutions of laser 
polarized Xenon can be used to deliver polarized Xenon 
through the blood. The presence of the lipid in the delivery 
vehicle both retards penetration of the Xenon through the 
RBC membrane and protects the xenon polarization from 
rapidly decaying. 
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The use of different Solutions for administering hyperpo 
larized Xenon to blood and tissues is very promising for 
'Xe Spectroscopic Imaging, Chemical Shift Imaging or in 
vivo Localized NMR Spectroscopy in tissues. 'Xe NMR 
parameters, Such as the relaxation times, may prove useful 
to probe the State of health of tissueS or the malignancy of 
tumors. Moreover, Xenon dissolves readily in fat, and hyper 
polarized xenon MRI may be an alternative to conventional 
proton MRI of fatty tissues. 
Example 6 
Example 6 demonstrates the utility of perfluorocarbons as 
delivery vehicles for laser polarized Xenon. 
Perfluorocarbon compounds are generally chemically 
inert and non-toxic. Interestingly, perfluorocarbon emul 
Sions are able to absorb and transport oxygen and carbon 
dioxide. A representative perfluorocarbon emulsion, FLUO 
SOLE (Green Cross, Osaka, Japan), was chosen as a prom 
ising prototypical delivery vehicle for xenon. FLUOSOLOR 
is an emulsion which contains 20% perfluorocarbon and is 
approved by the U.S. F.D.A. for intravascular administration 
in humans as a blood Substitute. 
A solution of hyperpolarized xenon in FLUOSOLOR was 
prepared in the same manner as described for the Saline 
Solution of hyperpolarized Xenon, however, the Shaker was 
charged with FLUOSOL(R) rather than saline. The FLUO 
SOLOR solution was charged with laser polarized 'Xe and 
an aliquot (1 mL) of this Solution was added to human blood 
(1 mL). The spectra were obtained on a Bruker AM-400 
Spectrometer. 
6.2 Results 
FIG. 6B shows a 'Xe NMR spectrum acquired after 
mixing the FLUOSOL(R)/xenon solution with blood. The 
peak at 216 ppm corresponds to Xenon in the RBC, whereas 
the broad peak centered around 110 ppm (FIG. 6B, inset) 
arises from Xenon in the FLUOSOLCE Solution. Xenon in 
pure FLUOSOLR has a chemical shift of 110 ppm and the 
peak exhibits a broadening which is Similar to that observed 
in the spectrum of the xenon/blood/FLUOSOL(R) solution. 
The ratio of the integrated intensities of the broad and 
narrow peaks is approximately 3. The T of the narrow peak 
was measured to be 13+1 S. This T is, similar to that 
measured for xenon in INTRALIPID(R); longer than that 
measured for xenon in the RBC/plasma sample. The results 
with FLUOSOL(R) Suggest that xenon exchanges between 
the interior of the RBC and an environment characterized by 
a Xenon relaxation time which is longer than that exhibited 
by intracellular xenon. Presumably, the xenon which has the 
longer relaxation time resides in the FLUOSOLOR. These 
results have implications for the selective MRI/NMR of 
Xenon which has been transferred to tissues. 
Also acquired was a two-dimensional MR image of 'Xe 
dissolved in fresh human blood (FIG. 7). The image was 
acquired immediately after the blood was mixed with a 
saline solution saturated with hyperpolarized 'Xe. 
The above example illustrates that perfluorocarbon emul 
Sions are useful delivery vehicles for hyperpolarized noble 
gases. Also demonstrated is the feasibility of acquiring an 
MR image of 'Xe dissolved in blood when the 'Xe is 
administered to the blood as a Saline Solution and, therefore, 
has a shorter T, than is observed for 'Xe in a fluorocarbon 
delivery agent. 
Example 7 
7.1 Materials and Methods 
Solutions of hyperpolarized 'Xe in partially deuterated 
benzene (25% CDH, 75% C.D.) were prepared as 
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described above for saline solutions of 'Xe with the 
exception that the Shaker was charged with the benzene 
solution rather than saline. Typically, 4x10" mol of 
enriched 'Xe (80%, EG&G Mound) were used in one 
experiment at a pressure of 1 atm. 'Xe NMR was per 
formed at 51 MHz on a Quest 4300 spectrometer (Nalorac 
Cryogenics, Martinez, Calif., U.S.A.) with a home built 
probe and a tipping angle of 3. "H NMR was performed at 
185 MHz with a home built probe and a tipping angle of 3. 
Time-resolved two-dimensional MR images of 'Xe 
were obtained using the fast low-angle shot (FLASH) imag 
ing method on the Quest 4300 instrument using a tipping 
angle of 3 for each of the 64 signal acquisitions. The 
frequency-encoding gradient was 3.5G/mm. The Step size 
of the phase-encoding gradient pulses, which were 500 uS 
long, was 0.063 G/mm. The diameter of the sample tube was 
7 mm and the Solution occupied a region within the tube of 
length 15 mm. The images were 64x128 pixel images. 
The time-resolved distribution (in seconds) of an 
unshaken Sample of partially deuterated benzene was 
obtained from MRI projections along the tube axis (Z). The 
imaging field gradient for the acquisition of these images 
was 2.6 G/mm. 
Two-dimensional MR images of the SPINOE-enhanced 
"H signals were obtained at 2 and 6 minutes after hyperpo 
larized 'Xe was admitted to the sample tube containing 
normal benzene. The images were taken by the echo planar 
imaging method in 24 ms. The frequency encoding gradient 
was 3.15 G/mm; the phase-encoding gradient pulses were 
0.14 G/mm and 50 uS long. The image dimension was 
128x32 pixels, and the image was Zero-filled to 256x256 
pixels in data processing. 
The methods used and the results obtained in this example 
are discussed in detail in Navon, G., et al., Science, 271: 
1848-1851 (1996), which is herein incorporated by refer 
CCC. 
7.2 Results 
In the following example, the preliminary experiments 
designed to probe the SPINOE between hyperpolarized 
Xenon and protons in Solution are described. When hyper 
polarized 'Xe is dissolved in liquids, a time-dependent 
departure of the proton Spin from its thermal equilibrium 
was observed. The variation in magnetization was an unex 
pected manifestation of the nuclear Overhauser effect 
(NOE), a consequence of cross-relaxation between the spins 
of solution protons and 'Xe. SPINOE has been used to 
monitor time dependent magnetic resonance images and 
high resolution NMR spectra of Solution spins as they 
encounter the migrating Xenon atoms. 
The time dependence of the 'Xe NMR signal intensity 
observed when hyperpolarized 'Xe is dissolved in liquid 
benzene is shown in FIG. 8. The observed spin-lattice 
relaxation time of 'Xe in solution, a combination of the 
gas and Solution relaxation times, is ~200S in normal ben 
Zene and ~1000s in the partially deuterated sample 
(MoschoS, A, et al., J. Magn. Reson. 95: 603 (1991); and 
Diehl, P., et al., J. Magn. Reson. 88: 660 (1990). The 
difference between these two values demonstrates the effect 
of magnetic dipolar coupling between Hand 'Xe spins on 
the relaxation of the 'Xe magnetization; the same coupling 
underlies the croSS relaxation between the Xenon and proton 
spin systems. For the initial NOE experiments, the partially 
deuterated liquids were used to promote the effects of croSS 
relaxation over the potentially limiting auto-relaxation of the 
proton Spins. 
The effect of the dissolved hyperpolarized 'Xe on the 
"H magnetization in liquid benzene is illustrated in FIG. 9. 
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The proton NMR signal exhibits a positive or negative 
time-dependent NOE, depending on the sign of the 'Xe 
magnetization, which is determined by the helicity of the 
laser light or the orientation of the magnetic field in the 
optical pumping Stage. The fractional enhancement of the 
proton magnetization over its thermal equilibrium value is 
typically -0.1 for benzene, and between 0.5 and 2 for the 
partially deuterated Sample. 
Based on the theory of the nuclear Overhauser effect, the 
following expression can be derived for the maximum 
change in the polarization of the Solvent nuclei (I) due to 
cross relaxation with the dissolved gas (S): 
(6) S.(to) - So 
So 
yS(S+ 1) 
l:(to) to Oisy (1 + 1) 
o O 
where Y and Y are the magnetogyric ratioS of the nuclear 
Spins, Ois the croSS-relaxation rate, and p is the auto 
relaxation rate of the I Spins. The croSS-relaxation rate Os 
has the same value, Os=1.9x10'S', for both benzene and 
partially deuterated benzene Solutions, So the difference in 
the maximum enhancement of the proton polarization in 
these two Solutions originates from the different proton 
relaxation rates, p=(20s) in benzene and p=(160s) in 
the partially deuterated Solution. Given the Spin quantum 
numbers and the magnetogyric ratioS of the two nuclei, 
I=S=1/2, Y=2.67x10 rad T'S', and Y=-7.44x107 rad 
T'S', and the enhancement of the 'Xe polarization at the 
time t, when the proton magnetization reaches its maximum 
(minimum), S2(t)/Sas6000, the maximum proton enhance 
ment is estimated to be 0.06 in CH and 0.5 in the partially 
deuterated Solution, in general agreement With the measured 
values. 
The high spin-polarization and the Slow relaxation of 
'Xe in the solvent allow for a detailed observation of the 
dissolution process and the flow of xenon in the solvent by 
means of MRI. FIG. 10 shows two-dimensional MRI pro jections along the vertical axis of the sample tube. Xenon is 
found to accumulate first at the bottom of the tube, estab 
lishing a gradient in Xenon concentration and continues to 
dissolve into the benzene as the Solution gradually becomes 
saturated. A detail of this process is shown in FIG. 11, where 
a Series of the one-dimensional image intensities along the 
tube axis reflects the time-dependent spatial distribution of 
the Xenon. The descent of Xenon in the Sample tube occurs 
because of density differences between the Solution and pure 
benzene. The heavier Xenon-rich regions of the Solution, 
which form at the top of the solution by diffusion of the 
Xenon into the Solvent, gravitate to the lower part of the tube 
by natural convection, ultimately filling the tube with Satu 
rated Xenon Solution. 
Because of the SPINOE enhancement of the proton spins 
proximate to the dissolved hyperpolarized Xenon, the Xenon 
concentration gradient is expected to induce a gradient in the 
proton magnetization. Indeed, as shown in FIG. 12, the 
benzene proton magnetization images display a time depen 
dent gradient consistent with the Spatial distribution of 
Xenon shown in FIGS. 10 and 11. In fact, differential 
SPINOE enhancements of proton NMR can be observed in 
Solutions containing more than one component or in mol 
ecules possessing nuclei with different chemical shifts, mak 
ing it possible to explore the partitioning and Selective 
asSociation of the hyperpolarized gas. 
The foregoing results indicate that it is possible to image 
not only the hyperpolarized Xenon, but also the environment 
in which it is accommodated, a finding which has implica 
15 
25 
35 
40 
45 
50 
55 
60 
65 
28 
tions for both materials and medical applications, for Xenon 
as well as for helium. Because the equilibrium polarization 
of the Solution spins, S is proportional to the magnetic field, 
B, the relative SPINOE is inversely proportional to B, and 
is thus expected to be more pronounced at the lower mag 
netic fields normally used in medical imaging. Furthermore, 
Since the nuclear Overhauser effect depends on the proxim 
ity of the Xenon nucleus and the neighboring Spins, as well 
as their relative translational motion, a large SPINOE is 
anticipated in Systems where the noble gas atoms are par 
tially immobilized in materials, Miller, J. B., et al., Macro 
molecules 26: 5602 (1993), or temporarily bound to mol 
ecules Such as proteins, Tilton, R. F., et al., Biochemistry 21, 
6850 (1982), even in the presence of relatively fast proton 
relaxation. The window is thus opened to other potential 
applications where Xenon may be adsorbed in materials, on 
Surfaces, or in biological molecules and organisms. 
Example 8 
This example illustrates the utility of 'Xe - 'HSPINOE 
Spectroscopy for Studying the dynamical and structural 
characteristics of molecules in Solution. That the coupling 
between laser-polarized 'Xe and protons in a 
p-nitrotoluene Solution is due to nuclear Spin dipolar cou 
pling modulated by diffusive motion is demonstrated. 
8. 1 Materials and Methods 
The Samples were generally prepared as described in the 
examples above. The pulse sequence used to obtain SPINOE 
data is a heteronuclear version of the difference NOE pulse 
Sequence originally Suggested by Stonehound, J., et. al. J. 
Am. Chem. Soc. 116: 6037 (1994) for homonuclear NOE 
studies. One method for observing SPINOEs is simply to 
acquire the proton Signal as a function of time after laser 
polarized'Xe is introduced to the solution. The deviation 
of the proton Signal from its thermal equilibrium value 
determines the signal due to SPINOE from laser 
polarized'Xe. However, this method relies on a subtrac 
tion of two large signals (with and without SPINOE), and 
this subtraction limits the sensitivity of the experiment to 
only those SPINOE signals greater than about one percent of 
the equilibrium Signal. This new Sequence is advantageous 
compared to the conventional SPINOE method since the 
equilibrium Signal can be Suppressed by two orders of 
magnitude or more. This type of Sequence has enabled 
measurements of NOEs less than 10" of the equilibrium 
Signal. 
The difference SPINOE sequence is shown in FIG. 13. 
The Saturation of proton resonances is first achieved by 
applying a train of proton JL/2 pulses, and this Saturation is 
maintained with the proton at pulses during the mixing time 
when the SPINOE occurs. The timing of the It pulses is 
adjusted to give optimal Saturation. ATL pulse is also applied 
to the 'Xe resonance at the same time of the proton at pulse 
so that the proton signal due to SPINOE will be accumulated 
over the entire mixing time. Odd numbers of Such at pulse 
pairs were used so that each acquisition inverted the 'Xe 
magnetization; thus the Subtraction of two consecutive Sig 
nals effectively removed all contributions to the signal that 
did not originate from SPINOE. 
8.2 Results 
Polarization transfer from laser-polarized Xenon to 
p-nitrotoluene in a Solution of perdeuterated benzene was 
observed. p-nitrotoluene is a simple molecule that does not 
show binding of Xenon in Solution; thus we anticipated that 
its couplings of its protons to Xenon would be similar to that 
of benzene protons. The difference SPINOE proton spectra 
with laser-polarized 'Xe are shown in FIG. 14A and FIG. 
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14B. The 'Xe polarization is negative in FIG. 14A and 
positive in FIG. 14B and the magnetization transfer to 
proton is found to be negative and positive, respectively. 
This observation is consistent with a correlation time that is 
much shorter than the inverse of the Larmor frequencies of 
"H and 'Xe, in which case the cross-relaxation constant 
Os would be positive. From the initial rise of the proton 
SPINOE signal intensity, we obtain the values of Os for the 
aromatic and methyl protons to be similar to that for benzene 
protons and the theoretical estimate of the croSS-relaxation 
rate due to dipolar coupling modulated by molecular diffu 
Sion. 
The above example demonstrates the utility of 'Xe - "H 
SPINOE spectroscopy for studying the dynamical and struc 
tural characteristics of molecules in Solution. That the cou 
pling between laser-polarized 'Xe and protons in a 
p-nitrotoluene Solution is due to nuclear Spin dipolar cou 
pling modulated by diffusive motion is demonstrated. 
Further, it has been shown that the sign of the SPINOE 
signal is influenced by the sign of the 'Xe polarization. 
Example 9 
This example demonstrates the effect of 'Xe binding to 
a molecule in solution on the observed SPINOE signal(s) 
arising from that molecule. A cyclic polysaccharide, 
cyclodextrin, was chosen as a model compound. 
9.1 Materials and Methods 
Hyperpolarized Xenon and mixtures of hyperpolarized 
Xenon and cyclodextrins were prepared generally as dis 
cussed above. SPINOE signals of 0.05 M cyclodextrin 
Solutions in deuterated DMSO were measured as described 
above in Example 8. 
9.2 Results 
C-Cyclodextrin is a naturally occurring host molecule 
composed of Six D-glucose units linked head to tail in a 1C, 
4-relationship to form a ring known as a cyclohexaamylose. 
It has a relatively inflexible doughnut Shaped structure 
where the top of the molecule has twelve hydroxyl groups 
from positions 2 and 3 of the glucose units and the bottom 
has the 6 primary hydroxyl groups from position 6. The 
equilibrium proton Spectrum of C-cyclodextrin in deuterated 
DMSO is displayed in FIG. 15. Cyclodextrins are cyclic 
glucopyranose oligomers that possess a hydrophobic bind 
ing pocket, Saenger, W., Angew. Chem. Int. Ed. 19: 344 
(1980). The hydrophobic binding properties of cyclodextrins 
permit them to complex a number of different guest Species, 
from drugs to noble gases, SZeitli, J., Cyclodextrin 
Technology, Kluwer-Academic, Dordrecht, 1988. 
Specifically, it has been shown in NMR studies that 
C-cyclodextrin complexes Xenon, Bartik, K., et al., J. Magn. 
Res. B, 109: 164 (1995). 
The first evidence of Strong couplings between Xenon and 
C-cyclodextrin is the reduced 'Xe T in the solution of 
C-cyclodextrin. For example, the measured 'Xe T was 20 
s in 0.1 M C-cyclodextrin solution in deuterated DMSO, 
compared to a T-500s in 0.1 M p-nitrotoluene in deuter 
ated benzene. This increase in the apparent relaxation rate of 
Xenon is due to the dipolar coupling between Xenon and the 
protons of C-cyclodextrin; this coupling not only determines 
the croSS-relaxation of the two Spins, but also contributes to 
the Xenon auto-relaxation. 
In order to study the effects of xenon binding on 'Xe 
H SPINOE, SPINOEs from laser-polarized xenon to 
C-cyclodextrin dissolved in a Solution of perdeuterated 
dimethyl sulfoxide (DMSO) were observed. The proton 
SPINOE spectra of C-cyclodextrin in the presence of 'Xe 
of negative polarization and of positive polarization are 
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shown in FIG.16 and FIG. 17, respectively. The assignment 
of the proton resonance has been reported in other work, 
Djedaini, F., et al., J. Mol. Struct., 239: 161 (1990). In 
contrast to the SPINOE spectra of p-nitrotoluene, the 
SPINOE signal intensities for various protons of 
C-cyclodextrin are Substantially different. The Strongest 
SPINOEs are observed from H3 and H5, protons located on 
the inside of the cyclodextrin cavity. The SPINOE signals 
from the outer protons H2, H4, H1, however, are about a 
factor of 6 Smaller. This difference in the Xenon coupling to 
various protons can be expected because Such dipolar cou 
pling is highly Sensitive to the relative distance between 
Spins. One can derive a ratio of the distances between 
Xenon-H3.H5 and xenon-H1, H2,H4 to be 1/v6=1/1.35. 
The percentage SPINOE signal is significantly larger than 
that from p-nitrotoluene Solution. Taking into account the 
Xenon pressures in the Sample cell and the magnetic fields 
applied in the different experiments of p-nitrotoluene and 
C-cyclodextrin, we estimate that the ratio of the croSS 
relaxation rates of C-cyclodextrin and p-nitrotoluene is 
approximately 100. This large increase in the overall cou 
pling constant can be attributed to significant binding 
between Xenon and C-cyclodextrin molecules. Although 
smaller, the SPINOE signals from the three hydroxyl pro 
tons are also observable. 
Additionally, the Xenon coupling constants have been 
compared for C-cyclodextrin and B-cyclodextrin, where 
B-cyclodextrin is a Seven-unit cyclodextrin ring. Even 
though the size of B-cyclodextrin is merely 15% larger than 
C-cyclodextrin, its binding of Xenon is dramatically reduced 
and the coupling constants are two orders of magnitude 
Smaller, essentially equivalent to the coupling constants of 
p-nitrotoluene. 
In the above example, it was demonstrated that the 
off-equilibrium polarization of Xenon can be transferred to 
other nuclear Species, Such as protons. Thus, hyperpolarized 
Xenon can be exploited as a contrast agent for protons. 
Moreover, it can be used to elucidate Structures of biologi 
cally relevant molecules, Such as proteins, by Selective 
polarization transfer to the protons of the Specific Sites where 
the Xenon binds. 
Example 10 
This example describes the in Vivo use of hyperpolarized 
Xenon dissolved into a lipid vehicle. Optically pumped 
Xenon was dissolved into a lipid emulsion as described in 
Example 5 and injected intravenously into a rat. The 'Xe 
NMR spectra from the region of the heart and liver were 
recorded as a function of time. 
10.1 Materials and Methods 
The laser polarized Xenon and the Solution of laser 
polarized xenon in INTRALIPID(R) were prepared essen 
tially as described in the preceding examples. 
Male rats weighing 200-250 grams were anesthetized by 
intramuscular injection of ketamine/Xylazine/acepromazine 
(30/3/0.6 mg/kg). Supplemental intramuscular doses were 
administered as needed to maintain anesthesia. A venous 
catheter was placed into a tail vein, and the receiver/ 
transmitter Surface coil was placed over the heart and liver 
(FIG. 18). Acquisitions began at start of the injection. Prior 
to each experiment the rat was placed in lateral recumbency 
into the magnet. At the conclusion of each experiment, the 
catheter was removed and the rat was returned to its cage to 
recover from anesthesia. 
The 'Xe NMR spectra were obtained on a home-built 
NMR spectrometer interfaced with a Bruker 2.35 T magnet 
(xenon frequency: 27.68 MHz, bore diameter: 25 cm). The 
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receiver-transmitter Surface coil had a diameter of 3.5 cm. 
For the spectroscopy experiment, spectra were obtained 
every Second (pulse angle:s20). 
10.2 Results 
A series of xenon NMR spectra were taken from the 
beginning of the intravenous injection of the Xenon/ 
INTRALIPID(R) Solution. A spectrum representing an aver 
age of the sixth through twelfth scans is shown in FIG. 19, 
the time-dependence of the integrated Signal is shown in the 
inset. It was anticipated that the Intralipid would initially 
accumulate in the liver; it is likely that the initial rise in 
Signal amplitude reflects this accumulation, while the Sub 
Sequent decay is due to wash-out, Xenon relaxation, and the 
application of rf pulses. 
This example demonstrates the feasibility of using lipid 
Solutions of hyperpolarized Xenon to deliver the Xenon via 
an intravenous administration route. Also illustrated is that 
in Vivo Spectra of the hyperpolarized Xenon can be readily 
obtained. 
Example 11 
This example describes the use of 'Xe MR imaging to 
obtain images of the in Vivo distribution of hyperpolarized 
Xenon in the rat. The hyperpolarized Xenon was adminis 
tered intramuscularly as a Saline Solution. 
11.1 Materials and Methods 
The methods for preparing the hyperpolarized Xenon and 
a Saline Solution of the hyperpolarized Xenon have been 
described in previous examples. The rats, anesthesia and 
apparatus were as described in Example 10, above. For the 
imaging experiment, the catheter was placed in the muscle 
of the rats thigh and Secured with tape. The Surface coil was 
placed over the injection site on the rats thigh. At the 
conclusion of the experiment, the catheter was removed and 
the rat was returned to the cage to recover from anesthesia. 
Axial images were acquired perpendicular to the coil 
using the FLASH sequence shown in FIG. 20. In the 
imaging experiment, ten two-dimensional 'Xe MR images 
were taken at intervals of approximately 7 S (with the 
exception of an 18 S delay between images 5 and 6) from the 
beginning of the injection of the Xenon/Saline Solution. 
11.2 Results 
Six of the images obtained are shown in FIG. 21, and 
depict the Signal intensity of the optically pumped Xenon in 
the upper part of the rat's hind leg. The central region of low 
Xenon Signal intensity likely corresponds to the rat’s femur. 
From the Six images, one may observe that the Signal 
intensity rises quickly and reaches a maximum at the Second 
image (b) (7 S after the start of the injection), and then 
decays in the following images. The initial rise in intensity 
is due to the accumulation of the Xenon/Saline Solution from 
the injection, while the Subsequent decay is due mostly to 
the application of the rf pulses (48 pulses of approximately 
5 degrees tipping angle), although Xenon relaxation and 
wash-out undoubtedly made additional contributions to this 
decay. The change in the pattern of the imageS Suggests that 
part of the Xenon/Saline Solution may have penetrated and 
diffused into the Surrounding tissue over the duration of the 
experiment. 
The major advantage of Saline water as the Xenon Solvent 
is the long Xenon T, which permits negligible loss of 
polarization over the injection time. However, the solubility 
of Xenon in Saline water is low with an Ostwald coefficient 
of only 0.0926 (the STP volume of xenon dissolved in 1 liter 
of liquid at 1 atm of gas pressure). Higher xenon concen 
trations can be obtained by using alternative Xenon Solvents 
(e.g. INTRALIPID(R) and FLUOSOL(R). Furthermore, the 
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Xenon partitioning properties of Such Solvents in biological 
tissues allow particular in Vivo applications. It was deter 
mined in previous in vitro Studies that Such Solvents can 
bring about a three-fold increase in the effective relaxation 
time of xenon in blood. Thus, administration of the polarized 
Xenon dissolved into one of these two classes of delivery 
vehicles is anticipated to improve the MR images acquired 
and to afford a longer temporal imaging window. 
Example 11 demonstrates that in vivo 'Xe MR images 
can be obtained and used to study the distribution of 
hyperpolarized Xenon in a living System. 
It is to be understood that the above description and 
examples are intended to be illustrative and not restrictive. 
Many embodiments will be apparent to those of skill in the 
art upon reading the above description and examples. The 
Scope of the invention should, therefore, be determined not 
with reference to the above description and examples, but 
should instead be determined with reference to the appended 
claims, along with the full Scope of equivalents to which 
Such claims are entitled. The disclosures of all articles and 
references, including patent applications and publications, 
are incorporated herein by reference for all purpose. 
What is claimed is: 
1. A method for analyzing a Sample containing a non 
noble gas NMR active nucleus, the method comprising: 
(a) contacting the Sample with a hyperpolarized noble gas, 
thereby transferring polarization from Said hyperpolar 
ized noble gas to the Sample, 
(b) Scanning a non-noble gas NMR active nucleus detec 
tion pulse Sequence to the Sample for detecting Said 
transferred polarization, whereby said transferred 
polarization detection is by means of nuclear magnetic 
resonance spectroscopy, magnetic resonance imaging, 
or both nuclear magnetic resonance SpectroScopy and 
magnetic resonance imaging, and 
(c) detecting the non-noble gas NMR active nucleus in the 
Sample by Said means of nuclear magnetic resonance 
Spectroscopy, magnetic resonance imaging, or both 
nuclear magnetic resonance Spectroscopy and magnetic 
resonance imaging. 
2. A method according to claim 1 in which said NMR 
active nucleus is a member Selected from the group con 
sisting of H, C, N, F, 'Si, P and combinations 
thereof. 
3. A method for analyzing a Sample containing a non 
noble gas NMR active nucleus, Said method comprising: 
(a) combining a hyperpolarized noble gas with a fluid to 
form a mixture, 
(b) contacting the Sample with Said mixture, thereby 
transferring polarization from Said hyperpolarized 
noble gas in Said mixture to the Sample; 
(c) Scanning a non-noble gas NMR active nucleus detec 
tion pulse Sequence to the Sample for detecting Said 
transferred polarization, whereby said transferred 
polarization detection is by means of nuclear magnetic 
resonance Spectroscopy, magnetic resonance imaging, 
or both nuclear magnetic resonance SpectroScopy and 
magnetic resonance imaging, and 
(d) detecting the non-noble gas NMR active nucleus in the 
Sample by Said means of nuclear magnetic resonance 
Spectroscopy, magnetic resonance imaging, or both 
nuclear magnetic resonance Spectroscopy and magnetic 
resonance imaging. 
4. A method in accordance with claim 3 in which said 
noble gas is a member Selected from the group consisting of 
Xenon, helium, neon, krypton and mixtures thereof. 
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5. A method in accordance with claim 3 in which said 
noble gas is Xenon. 
6. A method in accordance with claim 5 in which said 
Xenon is a member Selected from the group consisting of 
12Xe and Xe. 
7. A method in accordance with claim 3 in which said 
noble gas is He. 
8. The method in accordance with claim 3 further com 
prising the Step of hyperpolarizing Said noble gas prior to 
Step (a). 
9. The method in accordance with claim 8 in which said 
hyperpolarizing Step comprises hyperpolarizing Said noble 
gas through Spin exchange with an alkali metal. 
10. The method in accordance with claim 8 in which said 
hyperpolarizing Step comprises hyperpolarizing Said noble 
gas through metastability exchange. 
11. The method in accordance with claim 8 in which said 
hyperpolarizing Step comprises irradiating Said alkali metal 
with circularly polarized light. 
12. The method in accordance with claim 9 in which said 
alkali metal is selected from the group consisting of Na, 
3K, 13°Ce, 85 Rb and 7.Rb. 
13. A method in accordance with claim 3 further com 
prising freezing Said hyperpolarized noble gas to a Solid 
form prior to step (a). 
14. A method in accordance with claim 3 in which said 
fluid is a member Selected from the group consisting of 
water, physiological Saline, fluorocarbons, fluorocarbon 
emulsions, lipids, lipid emulsions and blood replacement 
preparations. 
15. A method in accordance with claim 3 in which said 
Sample comprises an organism or a portion of an organism. 
16. A method according to claim 15 in which said portion 
of an organism comprises an organ or tissue. 
17. A method in accordance with claim 3 in which said 
Sample is an organic or inorganic monomer. 
18. A method in accordance with claim 3 in which said 
Sample is an organic or inorganic polymer. 
19. A method in accordance with claim 3 in which said 
Sample is a biopolymer. 
20. A method in accordance with claim 19 in which said 
biopolymer is a member Selected from the group consisting 
of oligopeptides, polypeptides, antibodies and proteins. 
21. A method in accordance with claim 19 in which said 
biopolymer is a member Selected from the group consisting 
of oligonucleotides, RNA, mRNA, tRNA, DNA, 
chromosomes, genes and plasmids. 
22. A method in accordance with claim 19 in which said 
biopolymer is a member Selected from the group consisting 
of oligosaccharides, polysaccharides, glycoproteins, and 
mucopolysaccharides. 
23. A method in accordance with claim 3 in which the 
non-noble gas NMR active nucleus is a member selected 
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from the group consisting of H, C, N, F, 'Si, Pand 
combinations thereof. 
24. A method in accordance with claim 1 in which said 
non-noble gas NMR active nucleus detection pulse Sequence 
is a pulse Sequence for heteronuclear difference Spin polar 
ization induced nuclear Overhauser effect (SPINOE) NMR 
of a System comprising Said hyperpolarized noble gas and 
the non-noble gas NMR active nucleus, which comprises: 
(a) a non-noble gas NMR active nucleus C/2 pulse, 
(b) a non-noble gas NMR active nucleus at pulse applied 
Simultaneously with application of a noble gas It pulse, 
and 
(c) a non-noble gas MNR active nucleus L/2 pulse. 
25. A method in accordance with claim 3 in which said 
non-noble gas NMR active nucleus detection pulse Sequence 
is a pulse Sequence for heteronuclear difference Spin polar 
ization induced nuclear Overhauser effect (SPINOE) NMR 
of a System comprising Said hyperpolarized noble gas and 
the non-noble gas NMR active nucleus, which comprises: 
(a) a non-noble gas NMR active nucleus C/2 pulse, 
(b) a non-noble gas NMR active nucleus at pulse applied 
Simultaneously with application of a noble gas It pulse, 
and 
(c) a non-noble gas NMR active nucleus L/2 pulse. 
26. A method for analyzing a Sample containing a non 
noble gas NMR active nucleus, the method comprising: 
(a) contacting the Sample with a hyperpolarized noble gas, 
thereby transferring polarization from Said hyperpolar 
ized noble gas to the Sample, 
(b) Scanning a non-noble gas NMR active nucleus detec 
tion pulse Sequence to the Sample for detecting Said 
transferred polarization, whereby said transferred 
polarization detection is by means of nuclear magnetic 
resonance Spectroscopy, magnetic resonance imaging, 
or both nuclear magnetic resonance SpectroScopy and 
magnetic resonance imaging, wherein Said non-noble 
gas NMR active nucleus detection pulse Sequence is a 
pulse Sequence for heteronuclear difference Spin polar 
ization induced nuclear Overhauser effect (SPINOE) 
NMR of a System comprising Said hyperpolarized 
noble gas and the non-noble gas NMR active nucleus, 
which comprises: 
a non-noble gas NMR active nucleus II/2 pulse; 
a non-noble gas NMR active nucleus. It pulse, and 
a non-noble gas NMR active nucleus II/2 pulse; and 
(c) detecting the non-noble gas NMR active nucleus in the 
Sample by Said means of nuclear magnetic resonance 
Spectroscopy, magnetic resonance imaging, or both 
nuclear magnetic resonance Spectroscopy and magnetic 
resonance imaging. 
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